Improving fermentation organisms for ethanol production.
Patent Information
- Application Number
- JP2025517583
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-09-23
- Filing Date
- 2023-09-22
- Publication Date
- 2026-11-19
AI Technical Summary
The increasing demand for ethanol as a fuel and the availability of new strains of corn have created a need for improved ethanol production efficiency, as existing Saccharomyces cerevisiae strains used in the fuel ethanol industry face challenges in ethanol yield, by-product production, and fermentation efficiency.
Development of novel Saccharomyces cerevisiae strains, such as NRRL Y-68199, NRRL Y-68200, NRRL Y-68201, and NRRL Y-68202, which express heterologous polypeptides like glucoamylase and alpha-amylase, and are used in processes like simultaneous saccharification and fermentation (SSF) to enhance ethanol production from starch- and cellulose-containing materials.
These strains improve ethanol yield, reduce by-products like acetaldehyde and glycerol, and enhance temperature tolerance, resulting in higher fermentation efficiency and productivity.
Smart Images

Figure 00000068_0000 
Figure 00000068_0001 
Figure 00000069_0000
Abstract
Description
[Technical Field]
[0001] Reference to the deposit of biological material This application contains references to deposits of biological material, which deposits are incorporated herein by reference. [Background technology]
[0002] The production of ethanol from starch-containing materials is well known in the art. The production of ethanol as a biofuel has become a major industry, with over 2.5 billion gallons of ethanol produced worldwide in 2021.
[0003] The most commonly used industrially commercial process, often referred to as the "conventional process," involves liquefaction of gelatinized starch at high temperatures (approximately 85°C), typically using bacterial alpha-amylase, followed by simultaneous saccharification and fermentation (SSF), typically carried out anaerobically in the presence of glucoamylase and Saccharomyces cerevisae.
[0004] Yeast used to produce ethanol for use as a fuel, such as in the corn ethanol industry, require several characteristics to ensure cost-effective production of ethanol. These properties include ethanol tolerance, low by-product yield, rapid fermentation, and the ability to limit the amount of residual sugars remaining during fermentation. Such properties significantly affect the viability of an industrial process.
[0005] Yeasts of the genus Saccharomyces exhibit many of the characteristics required for ethanol production. In particular, strains of Saccharomyces cerevisiae are widely used for ethanol production in the fuel ethanol industry. Saccharomyces cerevisiae strains widely used in the fuel ethanol industry are capable of producing high yields of ethanol under fermentation conditions found, for example, in corn mash fermentation. An example of such a strain is the yeast used in the commercial ethanol yeast product called ETHANOL RED®.
[0006] In the fuel ethanol industry, strains of Saccharomyces cerevisiae are used to ferment sugars such as glucose, fructose, sucrose, and maltose to produce ethanol via the glycolytic pathway, which can be obtained from sources such as corn and other grains, cane juice, molasses, grape juice, fruit juice, and starch-containing root vegetables, and involves the breakdown of cellulosic material into glucose.
[0007] Although strains of Saccharomyces cerevisiae currently used in the fuel ethanol industry are highly suitable for ethanol production, the increasing demand for ethanol as a fuel and the increasing availability of starch in new strains of corn have created a growing need to improve ethanol production efficiency.
[0008] Therefore, there is a need for new, robust yeast strains of the genus Saccharomyces that can improve the efficiency of ethanol production in industrial-scale fermentations.
[0009] Furthermore, despite significant improvements in ethanol production processes over the past decade, there remains a desire and need to provide processes for producing ethanol from starch-containing materials and yeast that can be used in commercial-scale ethanol processes. Summary of the Invention [Means for solving the problem]
[0010] Described herein are, among other things, processes for producing ethanol from cellulose- or starch-containing materials, and yeasts suitable for use in such processes.
[0011] A first aspect is a method for producing a fermentation product from a cellulose-containing material and / or a starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) under suitable conditions with a fermentation organism to produce a fermentation product, wherein the fermentation organism is selected from the group consisting of strains deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty under accession numbers NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68203 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68204 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68205 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., Y-68202 (Saccharomyces cerevisiae strain MBG5318) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same properties as Saccharomyces cerevisiae MBG5225, Saccharomyces cerevisiae MBG5227, Saccharomyces cerevisiae MBG5307, or Saccharomyces cerevisiae strain MBG5318.
[0012] In one embodiment, the method includes recovering the fermentation product from the fermentation (eg, by distillation).
[0013] In one embodiment, fermentation and saccharification are carried out simultaneously via simultaneous saccharification and fermentation (SSF). In one embodiment, fermentation and saccharification are carried out sequentially (SHF).
[0014] In one embodiment, the fermentation product is ethanol.
[0015] In one embodiment, step (a) comprises contacting the starch-containing and / or cellulose-containing material with an enzyme composition.
[0016] In one embodiment, step (a) comprises saccharifying the starch-containing material, hi one embodiment, step (a) comprises the steps of: i) liquefying the starch-containing material at a temperature above the initial gelatinization temperature using an alpha-amylase; and ii) saccharifying using a glucoamylase.
[0017] In one embodiment, step (a) comprises saccharifying the cellulose-containing material. In one embodiment, the cellulose-containing material is pretreated. In one embodiment, the cellulose-containing material comprises bagasse.
[0018] In one embodiment, step (a) comprises contacting the cellulose-containing material with an enzyme composition, the enzyme composition comprising one or more enzymes selected from cellulase, AA9 polypeptide, hemicellulase, CIP, esterase, expansin, ligninolytic enzyme, oxidoreductase, pectinase, protease, and swollenin. In one embodiment, the cellulase is one or more enzymes selected from endoglucanase, cellobiohydrolase, and beta-glucosidase. In one embodiment, the hemicellulase is one or more enzymes selected from xylanase, acetyl xylan esterase, feruloyl esterase, arabinofuranosidase, xylosidase, and glucuronidase.
[0019] In one embodiment, the method results in a fermentation product yield of at least 0.25% (e.g., 0.5%, 0.75%, 1.0%, 1.25%, 1.5%, 1.75%, 2%, 3%, or 5%).
[0020] In one embodiment, the fermentation is carried out under low oxygen (eg, anaerobic) conditions.
[0021] In one embodiment, the fermenting organism has one or more of the following characteristics: Increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced maltose (DP2) production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduction of glycerol production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions.
[0022] A second aspect relates to yeast strains deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty under accession numbers NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5307), or derivatives thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase), and NRRL Y-68203 (Saccharomyces cerevisiae strain MBG5307). The present invention relates to a Saccharomyces cerevisiae strain having Saccharomyces cerevisiae MBG5225, Saccharomyces cerevisiae MBG5227, Saccharomyces cerevisiae MBG5307, or Saccharomyces cerevisiae MBG5318 or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same properties as Saccharomyces cerevisiae MBG5225, Saccharomyces cerevisiae MBG5227, Saccharomyces cerevisiae MBG5307, or Saccharomyces cerevisiae strain MBG5318.
[0023] In one embodiment, the strain has one or more of the following characteristics: Increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced maltose (DP2) production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduction of glycerol production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions.
[0024] A third aspect is a method for producing a derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), comprising: (a) introducing a first yeast strain into a first yeast strain selected from the group consisting of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), and NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318). (b) culturing a first yeast strain, Saccharomyces cerevisiae strain MBG5307, or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), or a second yeast strain that is a derivative thereof, under conditions that allow for recombination of DNA between the first and second yeast strains; (b) isolating a hybrid strain; and (c) optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as the first and / or second yeast strain.
[0025] A fourth aspect is directed to NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5225; NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5227; NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5318; or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5318. 1. A method for producing a derivative of Saccharomyces cerevisiae (Saccharomyces cerevisiae strain MBG5318), comprising: (a) providing (i) a first yeast strain and (ii) a second yeast strain that is NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), or a derivative thereof; (b) culturing the first yeast strain and the second yeast strain under conditions that permit recombination of DNA between the first and second yeast strains; and (c) culturing the first yeast strain and the second yeast strain under conditions that permit recombination of DNA between the first and second yeast strains. and screening or selecting a derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318).
[0026] In one embodiment, step (c) comprises screening or selecting hybrid strains that exhibit one or more defining characteristics of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318). In one embodiment, the method further comprises: (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first yeast strain and / or the second yeast strain until a derivative exhibiting the defining characteristics of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) is obtained.
[0027] In one embodiment, the culturing step (b) comprises: (i) sporulating the first yeast strain and the second yeast strain; and (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain.
[0028] A fifth aspect is a method for producing a recombinant derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), comprising: (a) introducing a recombinant derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae The present invention relates to a method for producing a yeast strain of Saccharomyces cerevisiae, comprising the steps of: (a) transforming Saccharomyces cerevisiae strain MBG5307, or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), or a derivative thereof, with one or more expression vectors (e.g., one or more expression vectors encoding a glucoamylase and / or an alpha-amylase); and (b) isolating the transformed strain.
[0029] A sixth aspect relates to a Saccharomyces cerevisiae strain produced according to any of the third, fourth or fifth aspects.
[0030] A seventh aspect relates to a method for producing ethanol, comprising incubating a Saccharomyces cerevisiae strain of the second or sixth aspect with a substrate comprising fermentable sugars under conditions that allow fermentation of the fermentable sugars to produce ethanol.
[0031] An eighth aspect relates to a composition comprising the Saccharomyces cerevisiae strain of the second or sixth aspect and one or more naturally occurring and / or non-naturally occurring components.
[0032] In one embodiment, the ingredient is selected from the group consisting of surfactants, emulsifiers, gums, swelling agents, and antioxidants.
[0033] In one embodiment, the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68199).
[0034] In one embodiment, the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68200).
[0035] In one embodiment, the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68201).
[0036] In one embodiment, the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68202).
[0037] In one embodiment, the Saccharomyces cerevisiae strain is in a viable form, in particular in a dry, creamed or compressed form. [Brief explanation of the drawings]
[0038] [Figure 1] FIG. 1 shows the improvement in ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red® under non-stress conditions.
[0039] [Figure 2] 1 shows the reduction in glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red®.
[0040] [Figure 3] FIG. 1 shows the improvement in ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red® under non-stress conditions.
[0041] [Figure 4] 1 shows the reduction in glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red®.
[0042] [Figure 5] FIG. 1 shows the improvement in ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red® under non-stress conditions.
[0043] [Figure 6] 1 shows the reduction in glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red®.
[0044] [Figure 7] FIG. 1 shows the improvement in ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5307 compared to Ethanol Red® under non-stress conditions.
[0045] [Figure 8] 1 shows the reduction in glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5307 compared to Ethanol Red®.
[0046] [Figure 9] FIG. 1 shows the improvement of ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red® under temperature and organic stress conditions.
[0047] [Figure 10] FIG. 1 shows the improvement of ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red® under temperature and organic stress conditions.
[0048] [Figure 11]FIG. 1 shows the improvement of ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red® under temperature and organic stress conditions. DETAILED DESCRIPTION OF THE INVENTION
[0049] definition Unless otherwise defined or clearly indicated by context, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.
[0050] Allelic variant: The term "allelic variant" refers to any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation and can result in polymorphism within a population. Genetic variations can be silent (no change in the encoded polypeptide) or can encode polypeptides with altered amino acid sequences. An allelic variant of a polypeptide is a polypeptide encoded by an allelic variant of a gene.
[0051] Alpha-amylase: The term "alpha amylase" refers to 1,4-alpha-D-glucan glucanohydrolase (EC.3.2.1.1), which catalyzes the hydrolysis of starch and other linear and branched 1,4-glucoside oligosaccharides and polysaccharides. Alpha-amylase activity can be determined using methods known in the art (e.g., using the alpha amylase assay described in WO 2020 / 023411).
[0052] Auxiliary active enzyme 9: The term "auxiliary active enzyme 9" or "AA9" refers to a polypeptide classified as a lytic polysaccharide monooxygenase (Quinlan et al., 2011, Proc. Natl. Acad. Sci. USA 208:15079-15084; Phillips et al., 2011, ACS Chem. Biol. 6:1399-1406; Lin et al., 2012, Structure 20:1051-1061). The AA9 polypeptide was previously classified as glycoside hydrolase family 61 (GH61) according to Henrissat, 1991, Biochem. J. 280:309-316 and Henrissat and Bairoch, 1996, Biochem. J. 316:695-696.
[0053] The AA9 polypeptide enhances the hydrolysis of cellulose-containing materials by enzymes having cellulolytic activity. Cellulolytic-enhancing activity can be determined by measuring the increase in reducing sugars or the increase in the total amount of cellobiose and glucose from the hydrolysis of cellulose-containing materials by cellulolytic enzymes under the following conditions, compared to a control hydrolysis without cellulolytic-enhancing activity and with an equal total protein loading (1-50 mg cellulolytic protein / g cellulose in PCS): 1-50 mg total protein / g cellulose in pretreated corn stover (PCS) (total protein consisting of 50-99.5 wt.% cellulolytic enzyme protein and 0.5-50 wt.% AA9 polypeptide protein), at a suitable temperature, such as 40°C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C, and at a suitable pH, such as 4-9, e.g., 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, or 8.5, for 1-7 days.
[0054] AA9 polypeptide-enhancing activity can be determined using a mixture of CELLUCLAST® 1.5L (Novozymes A / S, Bagsvaerd, Denmark) as a source of cellulolytic activity and beta-glucosidase, where the beta-glucosidase is present at a protein weight of at least 2-5% of the cellulosic protein load. In one embodiment, the beta-glucosidase is Aspergillus oryzae beta-glucosidase (e.g., recombinantly produced in Aspergillus oryzae according to WO 02 / 095014). In another embodiment, the beta-glucosidase is an Aspergillus fumigatus beta-glucosidase (e.g., recombinantly produced in Aspergillus oryzae as described in WO 02 / 095014).
[0055] The enhancing activity of the AA9 polypeptide can also be determined by incubating the AA9 polypeptide with 0.5% phosphoric acid swollen cellulose (PASC), 100 mM sodium acetate pH 5, 1 mM MnSO, 0.1% gallic acid, 0.025 mg / ml Aspergillus fumigatus beta-glucosidase, and 0.01% TRITON® X-100 (4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene glycol) at 40°C for 24-96 hours, and then measuring the glucose released from PASC.
[0056] AA9 polypeptide enhancing activity can also be determined according to WO 2013 / 028928 for high temperature compositions.
[0057] The AA9 polypeptide enhances the hydrolysis of cellulose-containing materials catalyzed by enzymes having cellulolytic activity by reducing the amount of cellulolytic enzyme required to reach the same degree of hydrolysis, preferably by at least 1.01-fold, e.g., at least 1.05-fold, at least 1.10-fold, at least 1.25-fold, at least 1.5-fold, at least 2-fold, at least 3-fold, at least 4-fold, at least 5-fold, at least 10-fold, or at least 20-fold.
[0058] Beta-glucosidase: The term "beta-glucosidase" refers to a beta-D-glucoside glucohydrolase (EC 3.2.1.21) that catalyzes the hydrolysis of terminal non-reducing beta-D-glucose residues with the release of beta-D-glucose. Beta-glucosidase activity can be determined using p-nitrophenyl-beta-D-glucopyranoside as a substrate according to the procedure of Venturi et al., 2002, J. Basic Microbiol. 42:55-66. One unit of beta-glucosidase is defined as 1.0 μmole of p-nitrophenolate anion produced per minute from 1 mM p-nitrophenyl-beta-D-glucopyranoside as a substrate in 50 mM sodium citrate containing 0.01% TWEEN® 20 at 25° C., pH 4.8.
[0059] Beta-xylosidase: The term "beta-xylosidase" refers to a beta-D-xyloside xylohydrolase (EC 3.2.1.37) that catalyzes the exohydrolysis of short beta(1→4)-xylooligosaccharides to sequentially remove D-xylose residues from the non-reducing ends. Beta-xylosidase activity can be determined using 1 mM p-nitrophenyl-beta-D-xyloside as a substrate in 100 mM sodium citrate containing 0.01% TWEEN® 20 at pH 5 and 40°C. One unit of beta-xylosidase is defined as 1.0 μmole of p-nitrophenolate anion produced per minute from 1 mM p-nitrophenyl-beta-D-xyloside in 100 mM sodium citrate containing 0.01% TWEEN® 20 at 40°C and pH 5.
[0060] Catalase: The term "catalase" refers to a hydrogen peroxide:hydrogen peroxide oxidoreductase (EC 1.11.1.6) that catalyzes the conversion of 2H2O2 to O2 + 2H2O. For purposes of the present invention, catalase activity is determined according to U.S. Pat. No. 5,646,025. One unit of catalase activity is equal to the amount of enzyme that catalyzes the oxidation of 1 μmole of hydrogen peroxide under assay conditions.
[0061] Cellobiohydrolase: The term "cellobiohydrolase" refers to 1,4-beta-D-glucan cellobiohydrolases (EC 3.2.1.91 and EC 3.2.1.176) that catalyze the hydrolysis of 1,4-beta-D-glucosidic bonds in cellulose, cellooligosaccharides, or any beta-1,4-linked glucose-containing polymer, releasing cellobiose from either the reducing (cellobiohydrolase I) or non-reducing (cellobiohydrolase II) ends of the chains (Teeri, 1997, Trends in Biotechnology 15:160-167; Teeri et al., 1998, Biochem. Soc. Trans. 26:173-178). Cellobiohydrolase activity can be determined according to the procedures described by Lever et al., 1972, Anal. Biochem. 47:273-279; van Tilbeurgh et al., 1982, FEBS Letters 149:152-156; van Tilbeurgh and Claeyssens, 1985, FEBS Letters 187:283-288; and Tomme et al., 1988, Eur. J. Biochem. 170:575-581.
[0062] Cellulolytic enzymes or cellulases: The terms "cellulolytic enzymes" or "cellulases" refer to one or more (e.g., several) enzymes that hydrolyze cellulose-containing materials. Such enzymes include endoglucanases, cellobiohydrolases, beta-glucosidases, or combinations thereof. Two basic approaches to measuring cellulolytic enzyme activity include (1) measuring total cellulolytic enzyme activity and (2) measuring individual cellulolytic enzyme activities (endoglucanases, cellobiohydrolases, and beta-glucosidases), as reviewed in Zhang et al., 2006, Biotechnology Advances 24:452-481. Total cellulolytic enzyme activity can be measured using insoluble substrates, such as Whatman No. 1 filter paper, microcrystalline cellulose, bacterial cellulose, algal cellulose, cotton, pretreated lignocellulose, etc. The most common total cellulolytic activity assay is the filter paper assay, which uses Whatman No. 1 filter paper as a substrate. The assay was established by the International Union of Pure and Applied Chemistry (IUPAC) (Ghose, 1987, Pure Appl. Chem. 59:257-68).
[0063] Cellulolytic enzyme activity can be determined by measuring the increase in sugar production / release during hydrolysis of a cellulose-containing material with a cellulolytic enzyme, compared to a control hydrolysis without added cellulolytic enzyme protein, under the following conditions: 1-50 mg cellulolytic enzyme protein / g cellulose in pretreated corn stover (PCS) (or other pretreated cellulose-containing material), at a suitable temperature, e.g., 40°C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C, and at a suitable pH, e.g., 4-9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0, for 3-7 days. Typical conditions are: 1 ml reaction, washed or unwashed PCS, 5% insoluble solids (dry weight), 50 mM sodium acetate pH 5, 1 mM MnSO4, 50°C, 55°C, or 60°C for 72 hours, sugar analysis by AMINEX® HPX-87H column chromatography (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
[0064] Coding sequence: The terms "coding sequence" or "coding region" refer to a polynucleotide sequence that specifies the amino acid sequence of a polypeptide. The boundaries of the coding sequence are generally determined by an open reading frame, which usually begins with the ATG start codon or alternative start codons such as GTG and TTG and ends with a stop codon such as TAA, TAG, and TGA. A coding sequence can be a sequence of genomic DNA, cDNA, synthetic polynucleotide, and / or recombinant polynucleotide.
[0065] Endoglucanase: The term "endoglucanase" refers to 4-(1,3;1,4)-beta-D-glucan 4-glucanohydrolase (EC 3.2.1.4), which catalyzes the endohydrolysis of beta-1,4 linkages in cellulose, cellulose derivatives (such as carboxymethylcellulose and hydroxyethylcellulose), lichenin, mixed beta-1,3-1,4 glucans such as cereal beta-D-glucans or xyloglucans, and 1,4-beta-D-glycosidic linkages in other plant materials containing cellulosic components. Endoglucanase activity can be determined by measuring the decrease in substrate viscosity or the increase in reducing ends as determined by a reducing sugar assay (Zhang et al., 2006, Biotechnology Advances 24:452-481). Endoglucanase activity can also be determined at pH 5, 40° C. using carboxymethylcellulose (CMC) as a substrate according to the procedure of Ghose, 1987, Pure and Appl. Chem. 59:257-268.
[0066] Expression: The term "expression" includes all steps involved in producing a polypeptide, including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion. Expression can be measured by techniques known in the art, such as, for example, measuring levels of mRNA and / or translated polypeptide to detect increased expression.
[0067] Expression vector: The term "expression vector" refers to a linear or circular DNA molecule that contains a polynucleotide encoding a polypeptide and is operably linked to a control sequence that effectuates its expression.
[0068] Fermentable medium: The term "fermentable medium" or "fermentation medium" refers to a medium containing one or more (e.g., two or several) sugars, such as glucose, fructose, sucrose, cellobiose, xylose, xylulose, arabinose, mannose, galactose, and / or soluble oligosaccharides, which can be partially converted (fermented) by a host cell into a desired product, such as ethanol. In some cases, the fermentation medium is obtained from a natural source, such as sugarcane, starch, or cellulose, or can be obtained by pre-treating the source by enzymatic hydrolysis (saccharification). The term fermentation medium is understood herein to refer to the medium before the fermenting organism is added, for example, the medium obtained from a saccharification process, and the medium used in a simultaneous saccharification and fermentation process (SSF).
[0069] Glucoamylase: The term "glucoamylase" (1,4-alpha-D-glucan glucohydrolase, EC 3.2.1.3) is defined as an enzyme that catalyzes the release of D-glucose from the non-reducing ends of starch or related oligo- and polysaccharide molecules. For purposes of the present invention, glucoamylase activity can be determined according to procedures known in the art, such as those described in WO 2020 / 023411.
[0070] Hemicellulolytic enzymes or hemicellulases: The terms "hemicellulolytic enzymes" or "hemicellulases" refer to one or more (e.g., several) enzymes that hydrolyze hemicellulosic materials. See, e.g., Shallom and Shoham, 2003, Current Opinion in Microbiology 6(3):219-228. Hemicellulases are key components in the decomposition of plant biomass. Examples of hemicellulases include, but are not limited to, acetylmannan esterase, acetylxylan esterase, arabinanase, arabinofuranosidase, coumaric acid esterase, feruloyl esterase, galactosidase, glucuronidase, glucuronoyl esterase, mannanase, mannosidase, xylanase, and xylosidase. Hemicellulose, the substrate for these enzymes, is a heterogeneous group of branched and linear polysaccharides that are linked to cellulose microfibrils in plant cell walls via hydrogen bonds, cross-linking them into a robust network. Hemicellulose is also covalently linked to lignin and forms a highly complex structure with cellulose. The variable structure and organization of hemicellulose requires the concerted action of many enzymes for its complete degradation. The catalytic modules of hemicellulases are either glycoside hydrolases (GHs), which hydrolyze glycosidic bonds, or carbohydrate esterases (CEs), which hydrolyze ester bonds of acetate or ferulic acid side chains. Based on their primary sequence homology, the catalytic modules can be assigned to GH and CE families. Some families with an overall similar fold can be further grouped into alphabetically labeled clans (e.g., GH-A). The most informative and up-to-date classification of these and other carbohydrate-active enzymes is available in the Carbohydrate-Active Enzymes (CAZy) database.Hemicellulolytic enzyme activity can be measured according to Ghose and Bisaria, 1987, Pure & Appl. Chem. 59:1739-1752, at a suitable temperature such as 40°C to 80°C, for example, 50°C, 55°C, 60°C, 65°C, or 70°C, and at a suitable pH such as 4 to 9, for example, 5.0, 5.5, 6.0, 6.5, or 7.0.
[0071] Heterologous Polynucleotide: The term "heterologous polynucleotide" is defined herein as a polynucleotide that is not native to the host cell, a naturally occurring polynucleotide that has structural modifications in the coding region, a naturally occurring polynucleotide whose expression has been quantitatively altered as a result of recombinant DNA techniques, e.g., engineering the DNA with a different (foreign) promoter, or a naturally occurring polynucleotide in a host cell that has one or more additional copies of the polynucleotide that quantitatively alters expression. A "heterologous gene" is a gene that comprises a heterologous polynucleotide.
[0072] Mature Polypeptide: The term "mature polypeptide" is defined herein as a biologically active polypeptide in its final form after translation and any post-translational modifications, such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc. A mature polypeptide sequence lacks a signal sequence, which can be determined using techniques known in the art (see, e.g., Zhang and Henzel, 2004, Protein Science 13:2819-2824). The term "mature polypeptide coding sequence" refers to a polynucleotide that encodes a mature polypeptide.
[0073] Pentose: The term "pentose" refers to a five-carbon monosaccharide (e.g., xylose, arabinose, ribose, lyxose, ribulose, and xylulose). Pentoses such as D-xylose and L-arabinose can be derived, for example, by saccharification of plant cell wall polysaccharides.
[0074] Pretreated Corn Stover: The term "pretreated corn stover" or "PCS" means a cellulose-containing material obtained from corn stover by treatment with heat and dilute sulfuric acid, alkaline pretreatment, neutral pretreatment, or any pretreatment known in the art.
[0075] Protease: The term "protease" is defined herein as an enzyme that hydrolyzes peptide bonds. This includes any enzyme that belongs to the EC 3.4 enzyme group, including each of its 13 subclasses. EC numbers refer to the Enzyme Nomenclature 1992 from NC-IUBMB, Academic Press, San Diego, California, including supplements 1-5, published in Eur. J. Biochem. 223:1-5 (1994); Eur. J. Biochem. 232:1-6 (1995); Eur. J. Biochem. 237:1-5 (1996); Eur. J. Biochem. 250:1-6 (1997); and Eur. J. Biochem. 264:610-650 (1999), respectively. The term "subtilase" refers to a subgroup of serine proteases according to Siezen et al., 1991, Protein Eng. 4:719-737 and Siezen et al., 1997, Protein Science 6:501-523. Serine proteases or serine peptidases are a subgroup of proteases characterized by having a serine in the active site that forms a covalent adduct with the substrate. Furthermore, subtilases (and serine proteases) are characterized by having two active site amino acid residues other than serine: histidine and aspartic acid residues. Subtilases can be divided into six subdivisions: the subtilisin family, thermitase family, proteinase K family, lantibiotic peptidase family, kexin family, and pyrrolysin family. The term "protease activity" refers to proteolytic activity (EC 3.4). Protease activity can be determined using methods described in the art (e.g., U.S. Patent Application Publication No. 2015 / 0125925) or using commercially available assay kits (e.g., Sigma-Aldrich).
[0076] Pullulanase: The term "pullulanase" refers to a starch debranching enzyme (EC 3.2.1.41) with pullulan 6-glucanohydrolase activity that catalyzes the hydrolysis of α-1,6-glycosidic bonds in pullulan, releasing maltotriose with a reducing carbohydrate end. For the purposes of the present invention, pullulanase activity can be determined according to the PHADEBAS assay or the sweet potato starch assay described in WO 2016 / 087237.
[0077] Sequence identity: The relatedness between two amino acid sequences or two nucleotide sequences is described by the parameter "sequence identity."
[0078] For purposes herein, the degree of sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, J. Mol. Biol. 1970, 48, 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., Trends Genet 2000, 16, 276-277), preferably version 3.0.0 or later. Optional parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled "longest identity" (obtained using the -nobrief option) is used as the percent identity and is calculated as follows: (Identical residues × 100) / (length of reference sequence−total number of gaps in alignment)
[0079] For purposes described herein, the degree of sequence identity between two deoxyribonucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 3.0.0 or later. Optional parameters used are a gap opening penalty of 10, a gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version in NCBI NUC4.4) substitution matrix. The output of Needle labeled "Longest Identity" (obtained using the -nobrief option) is used as the percent identity and is calculated as follows: (identical deoxyribonucleotides × 100) / (length of reference sequence−total number of gaps in alignment)
[0080] Xylanase: The term "xylanase" refers to 1,4-beta-D-xylan-xylohydrolase (EC 3.2.1.8), which catalyzes the endohydrolysis of 1,4-beta-D-xylosidic bonds in xylan. Xylanase activity can be determined at 37°C with 0.2% AZCL-arabinoxylan as a substrate in 0.01% TRITON® X-100 and 200 mM sodium phosphate, pH 6. One unit of xylanase activity is defined as 1.0 μmol of azurin produced per minute from 0.2% AZCL-arabinoxylan as a substrate in 200 mM sodium phosphate, pH 6, at 37°C and pH 6.
[0081] Xylitol dehydrogenase: The term "xylitol dehydrogenase" or "XDH" (also known as D-xylulose reductase) refers to an enzyme classified as EC 1.1.1.9 that catalyzes the conversion of xylitol to D-xylulose. Xylitol dehydrogenase activity can be determined using methods known in the art (e.g., Richard et al., 1999, FEBS Letters 457, 135-138).
[0082] Xylose isomerase: The term "xylose isomerase" or "XI" refers to an enzyme that can catalyze D-xylose to D-xylulose in vivo and convert D-glucose to D-fructose in vitro. Xylose isomerase is also known as "glucose isomerase" and is classified as EC 5.3.1.5. Due to the highly stable structure of the enzyme, xylose isomerase is an excellent model for studying the relationship between protein structure and function (Karimaki et al., Protein Eng Des Sel, 12004, 17(12):861-869). Xylose isomerase activity can be determined using techniques known in the art (e.g., the coupled enzyme assay using D-sorbitol dehydrogenase described by Verhoeven et al., 2017, Sci Rep 7, 46155).
[0083] Xylulokinase: The term "xylulokinase" or "XK" refers to an enzyme classified as EC 2.7.1.17 that catalyzes the conversion of D-xylulose to D-xylulose 5-phosphate. Xylulokinase activity can be determined using methods known in the art (e.g., Richard et al., 2000, FEBS Microbiol. Letters 190, 39-43).
[0084] References herein to "about" a value or parameter include embodiments relating to that value or parameter itself. For example, a statement referring to "about X" includes the embodiment "X." When used in conjunction with a measured value, "about" includes a range that encompasses at least the uncertainty associated with the method of measuring the particular value, and can include a range of plus or minus two standard deviations around the stated value.
[0085] Similarly, reference to a gene or polypeptide "derived from" another gene or polypeptide X includes gene or polypeptide X.
[0086] As used in this specification and the appended claims, the singular forms "a," "or," and "the" include plural referents unless the context clearly dictates otherwise.
[0087] It is to be understood that the embodiments described herein include "consisting of" and / or "consisting essentially of" embodiments. As used herein, the word "comprise" or variations such as "comprises" or "comprising" are used in the inclusive sense, i.e., specifying that the stated features are present, but not excluding that further features may be present or added in various embodiments, unless the context requires otherwise, either by clear language or necessary implication.
[0088] Detailed Description Described herein are, inter alia, fermentation organisms and methods for producing fermentation products, such as ethanol, from starch- and / or cellulose-containing materials. Applicants have engineered novel Saccharomyces cerevisiae strains with improved ethanol titer, increased temperature tolerance, increased sugar consumption, a high ethanol-to-glycerol ratio, and reduced by-products to maximize product yield. These characteristics are important for the industrial production of corn ethanol.
[0089] In one aspect, there is provided a method for producing a fermentation product from a cellulose-containing or starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) with a fermentation organism described herein; The method includes:
[0090] Steps a) and b) can be performed sequentially or simultaneously (SSF). In one embodiment, steps a) and b) are performed simultaneously (SSF). In another embodiment, steps a) and b) are performed sequentially.
[0091] Fermenting organisms In one embodiment, the fermenting organism is a Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5225.
[0092] In one embodiment, the fermenting organism is a Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5227.
[0093] In one embodiment, the fermenting organism is a Saccharomyces cerevisiae strain having deposit accession number Y-68201 (Saccharomyces cerevisiae strain MBG5307) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5307.
[0094] In one embodiment, the fermenting organism is a Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5318.
[0095] In one embodiment, the fermenting organism has one or more of the following characteristics: reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; reduced maltose (DP2) production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduction of glycerol production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions.
[0096] In one embodiment, a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 achieves an ethanol yield boost of more than 1.0%, such as more than 2.0%, for example more than 2.5%, for example about 2.9%, relative to Saccharomyces cerevisiae strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039), using the same process settings and conditions, such as those described herein.
[0097] In one embodiment, a fermenting organism having substantially the same properties as Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces acetaldehyde production by more than 10%, such as more than 20%, more than 30%, more than 40%, more than 45%, such as 5 to 60%, for example 30 to 50%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, such as those described herein.
[0098] In one embodiment, a fermentation organism having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 has increased temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, e.g., those described herein.
[0099] Increased temperature tolerance is advantageous because fermentation temperatures can fluctuate to some extent. During the early part of fermentation, plants often do not actively heat the fermentation. Therefore, temperatures can rise naturally due to yeast metabolism. Plants use heat exchangers to control early fermentation temperatures so they do not get too high. During most of the year, plants can easily control early temperatures, with peak temperatures typically around 34°C. However, in the summer, the cooling water used in the heat exchangers is not cold enough to control the temperature. Therefore, in plants without chillers (i.e., water refrigeration systems), early fermentation temperatures can reach above 36.5°C, which stresses the yeast.
[0100] In one embodiment, a fermenting organism having substantially the same properties as Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces maltose (DP2) production by more than 3%, such as more than 4%, more than 5%, more than 6%, more than 7%, such as 2 to 15%, for example 5 to 10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, such as those described herein.
[0101] In one embodiment, a fermentation organism having substantially the same properties as Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces glycerol production by more than 3%, such as more than 4%, more than 5%, more than 6%, more than 7%, such as 2 to 15%, for example 5 to 10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, such as those described herein.
[0102] The fermenting organism may also be a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318. As used herein, a "derivative" of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 is a strain derived from said strain, such as through mutagenesis, recombinant DNA techniques, conjugation, cell fusion, or cytoduction between yeast strains. A strain derived from Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 may be a direct progeny (i.e., the product of a cross between Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 and another strain or itself), or may be a distant progeny resulting from an initial cross between Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 and another strain or itself, followed by multiple subsequent crosses.
[0103] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 is a hybrid strain produced by culturing a first yeast strain with Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 under conditions that allow for combination of DNA between the first yeast strain and Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
[0104] In one embodiment, derivatives of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318. Derivatives of the genus Saccharomyces that exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 are generated using Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, respectively. In this regard, Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5307, or MBG5318 form the basis for preparing other strains having the defining characteristics of Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5307, or MBG5318. For example, a strain of the genus Saccharomyces that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 can be derived from Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 using methods such as classical mating, cell fusion, or cell transfer between yeast strains, mutagenesis, or recombinant DNA techniques.
[0105] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5225 exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225), under conditions that allow for combination of DNA between the first and second yeast strains; (b) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5225, for example, screening or selecting derivatives that have increased ethanol production in corn mash compared to the first strain; (c) optionally repeating steps (a) and (b) with the screening or selection strain as the first yeast strain and / or second yeast strain until a derivative of Saccharomyces cerevisiae strain MBG5225 is obtained that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225. can be generated by
[0106] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5227 exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) under conditions that allow for combination of DNA between the first and second yeast strains; (b) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5227, for example, screening or selecting derivatives that have increased ethanol production in corn mash compared to the first strain; (c) optionally repeating steps (a) and (b) with the screening or selection strain as the first yeast strain and / or second yeast strain until a derivative of Saccharomyces cerevisiae strain MBG5227 is obtained that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227. can be generated by
[0107] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5307 exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307) under conditions that allow for combination of DNA between the first and second yeast strains; (b) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5307, for example, screening or selecting derivatives that have increased ethanol production in corn mash compared to the first strain; (c) optionally repeating steps (a) and (b) with the screening or selection strain as the first yeast strain and / or the second yeast strain until a derivative of Saccharomyces cerevisiae strain MBG5307 is obtained that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307. can be generated by
[0108] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5318 exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318), under conditions that allow for combination of DNA between the first and second yeast strains; (b) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5318, for example, screening or selecting derivatives that have increased ethanol production in corn mash compared to the first strain; (c) optionally repeating steps (a) and (b) with the screening or selection strain as the first yeast strain and / or the second yeast strain until a derivative of Saccharomyces cerevisiae strain MBG5318 is obtained that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318. can be generated by
[0109] The first yeast strain can be any strain of yeast, provided that the DNA of the strain can be combined with that of the second yeast strain using methods such as classical mating, cell fusion, or cell transfer. Typically, the first yeast strain is a Saccharomyces strain. More typically, the first yeast strain is a Saccharomyces cerevisiae strain. Saccharomyces cerevisiae is as defined by Kurtzman (2003) FEMS Yeast Research, vol. 4, pp. 233-245. The first yeast strain can have desired properties sought to be combined with the defining characteristics of Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5307, or MBG5318. The first yeast strain may be, for example, any Saccharomyces cerevisiae strain, such as ETHANOL RED®. It is also understood that the first yeast strain may be Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318).
[0110] The first and second yeast strains are cultured under conditions that allow for the combination of DNA between the yeast strains. As used herein, "DNA combination" between yeast strains refers to the combination of all or part of the genomes of the yeast strains. The combination of DNA between yeast strains can be by any method suitable for combining the DNA of at least two yeast cells, and can include, for example, sporulation of yeast strains to produce haploid cells and subsequent hybridization of compatible haploid cells; cell induction; or mating methods involving cell fusion, such as protoplast fusion.
[0111] In one embodiment, the step of culturing a first yeast strain with a second yeast under conditions that allow combination of DNA between the first and second yeast strains comprises: (i) sporulating a first yeast strain and a second yeast strain; (ii) germinating spores produced by the first yeast strain and hybridizing them with spores produced by the second yeast strain; Includes.
[0112] In one embodiment, a method for producing a derivative of Saccharomyces cerevisiae strain MBG5225 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225 comprises: (a) providing (i) a first yeast strain and (ii) a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225); (b) sporulating the first yeast strain and the second yeast strain; (c) germinating spores of the first yeast strain and hybridizing them with germinated spores of the second yeast strain; (d) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5225, for example, screening or selecting derivatives that have increased ethanol production compared to the first strain and / or a higher ethanol yield from glucose during fermentation of corn mash than the first strain; (e) optionally repeating steps (b) to (d) with the screening or selection strain as the first and / or second yeast strain. Includes.
[0113] In one embodiment, a method for producing a derivative of Saccharomyces cerevisiae strain MBG5227 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 comprises: (a) providing (i) a first yeast strain and (ii) a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227); (b) sporulating the first yeast strain and the second yeast strain; (c) germinating spores of the first yeast strain and hybridizing them with germinated spores of the second yeast strain; (d) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5227, for example, screening or selecting derivatives that have increased ethanol production compared to the first strain and / or a higher ethanol yield from glucose during fermentation of corn mash than the first strain; (e) optionally repeating steps (b) to (d) with the screening or selection strain as the first and / or second yeast strain. Includes.
[0114] In one embodiment, a method for producing a derivative of Saccharomyces cerevisiae strain MBG5307 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 comprises: (a) providing (i) a first yeast strain and (ii) a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307); (b) sporulating the first yeast strain and the second yeast strain; (c) germinating spores of the first yeast strain and hybridizing them with germinated spores of the second yeast strain; (d) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5307, for example, screening or selecting derivatives that have increased ethanol production compared to the first strain and / or a higher ethanol yield from glucose during fermentation of corn mash than the first strain; (e) optionally repeating steps (b) to (d) with the screening or selection strain as the first and / or second yeast strain. Includes.
[0115] In one embodiment, a method for producing a derivative of Saccharomyces cerevisiae strain MBG5318 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 comprises: (a) providing (i) a first yeast strain and (ii) a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318); (b) sporulating the first yeast strain and the second yeast strain; (c) germinating spores of the first yeast strain and hybridizing them with germinated spores of the second yeast strain; (d) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5318, for example, screening or selecting derivatives that have increased ethanol production compared to the first strain and / or a higher ethanol yield from glucose during fermentation of corn mash than the first strain; (e) optionally repeating steps (b) to (d) with the screening or selection strain as the first and / or second yeast strain. Includes.
[0116] Methods for sporulating, germinating, and hybridizing yeast strains, particularly Saccharomyces strains, are known in the art and are described, for example, in Ausubel, F. M. et al. (1997) Current Protocols in Molecular Biology, Volume 2, pages 13.2.1 to 13.2.5 (John Willey & Sons Inc.); Chapter 7, "Sporulation and Hybridization of Yeast" by R. R. Fowell, in "The Yeasts," Volume 1, A. H. Rose and J. S. Harrison (Eds.), 1969, Academic Press.
[0117] In one embodiment, yeast strains can be cultured under conditions that allow cell fusion. Methods for generating intra- or inter-species hybrids using cell fusion techniques are described, for example, in Spencer et al. (1990) in, Yeast Technology, Spencer JFT and Spencer DM (Eds), Springer Verlag, New York.
[0118] In another embodiment, the yeast strain can be cultured under conditions that allow for cell transfer. Methods for cell transfer are described, for example, in Inge-Vechymov et al. (1986) Genetika 22:2625-2636; Johnston (1990) in, Yeast technology, Spencer JFT and Spencer DM (Eds), Springer Verlag, New York.
[0119] In one embodiment, screening or selecting for derivatives of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 comprises screening or selecting for derivatives with increased ethanol production compared to the first strain, and / or screening or selecting for hybrids with higher ethanol yields, e.g., as described in WO 2019 / 161227.
[0120] In one embodiment, a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, respectively, can be a mutant of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318. Methods for generating mutants of Saccharomyces yeast, particularly mutants of Saccharomyces cerevisiae, are known in the art and are described, for example, in Lawrence CW (1991) Methods in Enzymology, 194:273-281.
[0121] In another embodiment, a derivative of Saccharomyces cerevisiae strain MBG5225 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225 can be a recombinant derivative of Saccharomyces cerevisiae strain MBG5225. In another embodiment, a derivative of Saccharomyces cerevisiae strain MBG5227 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 can be a recombinant derivative of Saccharomyces cerevisiae strain MBG5227. In another embodiment, a derivative of Saccharomyces cerevisiae strain MBG5307 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 can be a recombinant derivative of Saccharomyces cerevisiae strain MBG5307. In another embodiment, a derivative of Saccharomyces cerevisiae strain MBG5318 that exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 can be a recombinant derivative of Saccharomyces cerevisiae strain MBG5318. Recombinant derivatives of the Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 are strains generated by introducing nucleic acids into the Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 using recombinant DNA techniques.Recombinant methods for introducing nucleic acids into Saccharomyces yeast cells, particularly strains of the genus Saccharomyces, are known in the art and are described, for example, in Ausubel, F. M. et al. (1997), Current Protocols in Molecular Biology, Volume 2, pages 13.7.1 to 13.7.7, published by John Wiley & Sons Inc.
[0122] In one embodiment, recombinant derivatives of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 have been prepared by genetically modifying the strain (or another derivative thereof) to express heterologous enzymes, such as the alpha-amylases and / or glucoamylases described herein (or any of the enzymes described in WO 2020 / 023411, the contents of which are incorporated herein by reference).
[0123] In one embodiment, a method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68199) comprises: (a) transforming Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225) with one or more expression vectors encoding heterologous enzymes, such as glucoamylase and / or alpha-amylase; (b) isolating the transformed strain; Includes.
[0124] In one embodiment, the derivative of Saccharomyces cerevisiae strain MBG5225 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225) under conditions that allow for combination of DNA between the first and second yeast strains; (b) isolating the hybrid strain; (c) optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as a derivative of the first yeast strain and / or Saccharomyces cerevisiae strain MBG5225; It can be prepared by
[0125] In one embodiment, a method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68200) comprises: (a) transforming Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) with one or more expression vectors encoding heterologous enzymes, such as glucoamylase and / or alpha-amylase; (b) isolating the transformed strain; Includes.
[0126] In one embodiment, the derivative of Saccharomyces cerevisiae strain MBG5227 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) under conditions that allow for combination of DNA between the first and second yeast strains; (b) isolating the hybrid strain; (c) optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as a derivative of the first yeast strain and / or Saccharomyces cerevisiae strain MBG5227; It can be prepared by
[0127] In one embodiment, a method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68201) comprises: (a) transforming Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307) with one or more expression vectors encoding heterologous enzymes, such as glucoamylase and / or alpha-amylase; (b) isolating the transformed strain; Includes.
[0128] In one embodiment, the derivative of Saccharomyces cerevisiae strain MBG5307 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307) under conditions that allow for combination of DNA between the first and second yeast strains; (b) isolating the hybrid strain; (c) optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as a derivative of the first yeast strain and / or Saccharomyces cerevisiae strain MBG5307; It can be prepared by
[0129] In one embodiment, a method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68202) comprises: (a) transforming Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318) with one or more expression vectors encoding heterologous enzymes, such as glucoamylase and / or alpha-amylase; (b) isolating the transformed strain; Includes.
[0130] In one embodiment, the derivative of Saccharomyces cerevisiae strain MBG5318 is: (a) culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318), under conditions that allow for combination of DNA between the first and second yeast strains; (b) isolating the hybrid strain; (c) optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as a derivative of the first yeast strain and / or Saccharomyces cerevisiae strain MBG5318; It can be prepared by
[0131] In some embodiments, derivatives of Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5307, or MBG5318 express glucoamylase and / or alpha-amylase. Derivatives expressing glucoamylase and / or alpha-amylase have been produced to improve ethanol yields and process economics by reducing enzyme costs, since some or all of the essential enzymes required to hydrolyze starch are produced by the yeast organism.
[0132] composition This aspect relates to formulated Saccharomyces yeast compositions comprising the yeast strains described herein and naturally occurring and / or non-naturally occurring components.
[0133] In one embodiment, the composition comprises Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225), Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227), Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307), or Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318). The composition can be, for example, cream yeast, compressed yeast, wet yeast, dry yeast, semi-dry yeast, crumble yeast, stabilized liquid yeast, or frozen yeast. Methods for preparing such yeast compositions are known in the art.
[0134] In one embodiment, the Saccharomyces cerevisiae strain is a dry yeast, such as active dry yeast or instant yeast. In one embodiment, the Saccharomyces cerevisiae strain is a crumbled yeast. In one embodiment, the Saccharomyces cerevisiae strain is a compressed yeast. In one embodiment, the Saccharomyces cerevisiae strain is a cream yeast.
[0135] In one embodiment, the composition comprises a Saccharomyces yeast described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and one or more ingredients selected from the group consisting of surfactants, emulsifiers, gums, swelling agents, and antioxidants and other processing aids.
[0136] surfactants The compositions described herein can include a Saccharomyces yeast strain described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable surfactant. In one embodiment, the surfactant is an anionic surfactant, a cationic surfactant, and / or a nonionic surfactant.
[0137] emulsifier The compositions described herein may include a Saccharomyces yeast strain described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable emulsifier. In one embodiment, the emulsifier is a fatty acid ester of sorbitan. In one embodiment, the emulsifier is selected from the group consisting of sorbitan monostearate (SMS), citric acid esters of monoglycerides, polyglycerol esters, and fatty acid esters of propylene glycol.
[0138] In one embodiment, the composition comprises a Saccharomyces yeast described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and Olindronal SMS, Olindronal SK, or Olindronal SPL, which contain compositions related to EP 1,724,336 (hereby incorporated by reference). These products are commercially available from Bussetti, Austria, for active dry yeast.
[0139] rubber The compositions described herein can include a Saccharomyces yeast described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable gum. In one embodiment, the gum is selected from the group of locust bean gum, guar gum, tragacanth gum, gum arabic, xanthan gum, and acacia gum, particularly for cream yeast, compressed yeast, and dry yeast.
[0140] Swelling agent The compositions described herein can include a Saccharomyces yeast described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable swelling agent. In one embodiment, the swelling agent is methylcellulose or carboxymethylcellulose.
[0141] antioxidants The compositions described herein can include a Saccharomyces yeast described herein, particularly Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable antioxidant. In one embodiment, the antioxidant is butylated hydroxyanisole (BHA) and / or butylhydroxytoluene (BHT) or ascorbic acid (vitamin C), particularly for active dry yeast.
[0142] Methods of Using Starch-Containing Materials In some embodiments, the methods described herein produce fermentation products from starch-containing materials. Starch-containing materials are well known in the art and contain two types of homopolysaccharides (amylose and amylopectin) linked by alpha-(1-4)-D-glycosidic bonds. Any suitable starch-containing starting material can be used. The starting material is generally selected based on the desired fermentation product, such as ethanol. Examples of starch-containing starting materials include cereals, tubers, or grains. Specifically, the starch-containing material can be corn, wheat, barley, rye, milo, sago, cassava, tapioca, sorghum, oats, rice, peas, beans, or sweet potatoes, or mixtures thereof. Also contemplated are waxy and non-waxy types of corn and barley.
[0143] In one embodiment, the starch-containing starting material is corn. In one embodiment, the starch-containing starting material is wheat. In one embodiment, the starch-containing starting material is barley. In one embodiment, the starch-containing starting material is rye. In one embodiment, the starch-containing starting material is milo. In one embodiment, the starch-containing starting material is rhizome. In one embodiment, the starch-containing starting material is cassava. In one embodiment, the starch-containing starting material is tapioca. In one embodiment, the starch-containing starting material is sorghum. In one embodiment, the starch-containing starting material is rice. In one embodiment, the starch-containing starting material is pea. In one embodiment, the starch-containing starting material is bean. In one embodiment, the starch-containing starting material is sweet potato. In one embodiment, the starch-containing starting material is oat.
[0144] Methods using starch-containing materials can include conventional processes (e.g., including a liquefaction step, described in more detail below) or raw starch hydrolysis processes. In some embodiments using starch-containing materials, saccharification of the starch-containing material occurs at a temperature above the initial gelatinization temperature. In some embodiments using starch-containing materials, saccharification of the starch-containing material occurs at a temperature below the initial gelatinization temperature.
[0145] liquefy In embodiments using a starch-containing material, the method may further include a liquefaction step carried out by subjecting the starch-containing material at a temperature above the initial gelatinization temperature to an alpha-amylase, and optionally to a protease and / or glucoamylase. Other enzymes, such as pullulanase and phytase, may also be present and / or added during liquefaction. In some embodiments, the liquefaction step is carried out before steps a) and b) of the described method.
[0146] The liquefaction step may be carried out for 0.5 to 5 hours, such as 1 to 3 hours, for example typically about 2 hours.
[0147] The term "initial gelatinization temperature" refers to the minimum temperature at which gelatinization of a starch-containing material begins. Generally, starch heated in water begins to gelatinize at about 50°C to about 75°C. The exact temperature of gelatinization depends on the particular starch and can be easily determined by one skilled in the art. Thus, the initial gelatinization temperature may vary according to the plant species, the particular variety of the plant species, and the growing conditions. The initial gelatinization temperature of a given starch-containing material can be determined as the temperature at which 5% of the starch granules lose birefringence using the method described by Gorinstein and Lii, 1992, Starch / Staerke 44(12):461-466.
[0148] Liquefaction is typically carried out at a temperature in the range of 70° C. to 100° C. In one embodiment, the liquefaction temperature is 75 to 95° C., e.g., 75 to 90° C., 80 to 90° C., or 82 to 88° C., e.g., about 85° C.
[0149] The jet cooking step can be carried out at a temperature of, for example, 110-145°C, 120-140°C, 125-135°C, or about 130°C for about 1-15 minutes, about 3-10 minutes, or about 5 minutes prior to liquefaction in the step.
[0150] The pH during liquefaction can be 4 to 7, for example, pH 4.5 to 6.5, pH 5.0 to 6.5, pH 5.0 to 6.0, pH 5.2 to 6.2, or about 5.2, about 5.4, about 5.6, or about 5.8.
[0151] In one embodiment, the process further comprises, prior to liquefaction: i) reducing the particle size of a starch-containing material, preferably by dry milling; ii) forming a slurry comprising a starch-containing material and water; Includes.
[0152] Starch-containing starting materials, such as whole grains, can be reduced in particle size by, for example, milling to open up the structure to increase surface area and allow for further processing. Generally, there are two types of processes: wet milling and dry milling. In dry milling, the whole kernel is milled and used. Wet milling results in good separation of the germ and meal (starch granules and proteins). Wet milling is often used where starch hydrolysates are used, for example, in the production of syrups. Both dry milling and wet milling are well known in the art of starch processing. In one embodiment, the starch-containing material is subjected to dry milling. In one embodiment, the particle size is reduced to 0.05-3.0 mm, e.g., 0.1-0.5 mm, or such that at least 30%, at least 50%, at least 70%, or at least 90% of the starch-containing material barely passes through a sieve having a 0.05-3.0 mm screen, e.g., a 0.1-0.5 mm screen. In another embodiment, at least 50%, e.g., at least 70%, at least 80%, or at least 90% of the starch-containing material barely passes through a sieve having a #6 screen.
[0153] The aqueous slurry may contain 10 to 55 w / w% dry solids (DS) of the starch-containing material, for example 25 to 45 w / w% dry solids (DS), or 30 to 40 w / w% dry solids (DS).
[0154] The alpha-amylase, optionally a protease, and optionally a glucoamylase may be added initially to the aqueous slurry to initiate liquefaction (dilution). In one embodiment, only a portion of the enzymes (e.g., about one-third) are added to the aqueous slurry, while the remaining enzymes (e.g., about two-thirds) are added during the liquefaction process.
[0155] Alpha-amylases and glucoamylases for use in liquefaction can be found in the art, for example, in WO 2020 / 023411, the contents of which are incorporated herein by reference. Similarly, examples of suitable proteases for use in liquefaction can be found in the art, for example, in WO 2018 / 222990, the contents of which are incorporated herein by reference.
[0156] Saccharification and fermentation of starch-containing materials In embodiments using starch-containing materials, a glucoamylase may be present and / or added in saccharification step a) and / or fermentation step b) or simultaneous saccharification and fermentation (SSF). The glucoamylase in saccharification step a) and / or fermentation step b) or simultaneous saccharification and fermentation (SSF) is typically different from the glucoamylase optionally added to any liquefaction steps listed above. In one embodiment, the glucoamylase is present and / or added together with a fungal alpha-amylase. Suitable glucoamylases for use in saccharification or SSF can be found in the art, for example, in WO 2020 / 023411, the contents of which are incorporated herein by reference.
[0157] When sequential saccharification and fermentation are performed, saccharification step a) can be carried out under conditions well known in the art. For example, saccharification step a) can last up to about 24 to about 72 hours. In one embodiment, pre-saccharification is performed. Pre-saccharification is typically carried out at a temperature of 30 to 65°C, typically about 60°C, for 40 to 90 minutes. Following pre-saccharification, in one embodiment, saccharification is carried out during fermentation in simultaneous saccharification and fermentation ("SSF"). Saccharification is typically carried out at a temperature of 20 to 75°C, preferably 40 to 70°C, typically about 60°C, and typically at a pH of 4 to 5, e.g., about pH 4.5.
[0158] Fermentation is carried out in a fermentation medium as known in the art, e.g., as described herein. The fermentation medium includes a fermentation substrate, i.e., a carbohydrate source that is metabolized by the fermenting organism. In accordance with the processes described herein, the fermentation medium may include nutrients and growth stimuli for the fermenting organism. Nutrients and growth stimuli are widely used in the art of fermentation and include nitrogen sources, e.g., ammonia; urea; vitamins; and minerals, or combinations thereof.
[0159] Generally, fermentation organisms such as yeast, including Saccharomyces cerevisiae, require a sufficient nitrogen source for growth and fermentation. Many supplemental nitrogen sources can be used as needed, and such nitrogen sources are well known in the art. The nitrogen source can be organic, such as urea, DDGS, wet cake, or corn mash, or inorganic, such as ammonia or ammonium hydroxide. In one embodiment, the nitrogen source is urea.
[0160] Fermentation can be carried out under low nitrogen conditions, for example, when using protease-expressing yeast. In some embodiments, the fermentation step is carried out with less than 1000 ppm supplemental nitrogen (e.g., urea or ammonium hydroxide), for example, less than 750 ppm, less than 500 ppm, less than 400 ppm, less than 300 ppm, less than 250 ppm, less than 200 ppm, less than 150 ppm, less than 100 ppm, less than 75 ppm, less than 50 ppm, less than 25 ppm, or less than 10 ppm supplemental nitrogen. In some embodiments, the fermentation step is carried out without supplemental nitrogen.
[0161] Simultaneous saccharification and fermentation ("SSF") is widely used in industrial-scale fermentation processes, particularly for the production of ethanol. When performing SSF, the saccharification step a) and the fermentation step b) are carried out simultaneously. There is no holding stage for saccharification, meaning that the fermentation organisms, such as yeast, and enzymes can be added together. However, separate addition of the fermentation organisms and enzymes is also contemplated. SSF is typically carried out at temperatures between 25°C and 40°C, e.g., between 28°C and 35°C, e.g., between 30°C and 34°C, or about 32°C. In one embodiment, the fermentation proceeds for 6 to 120 hours, particularly 24 to 96 hours. In one embodiment, the pH is between 4 and 5.
[0162] In one embodiment, a cellulolytic enzyme composition is present and / or added during saccharification, fermentation, or simultaneous saccharification and fermentation (SSF). Examples of such cellulolytic enzyme compositions can be found in the "Cellulolytic Enzymes and Compositions" section. The cellulolytic enzyme composition can be present and / or added together with a glucoamylase, such as those disclosed in the "Glucoamylases" section.
[0163] Methods of Using Cellulose-Containing Materials In some embodiments, the methods described herein produce fermentation products from cellulose-containing materials. The predominant polysaccharide in the primary cell walls of biomass is cellulose, followed by hemicellulose and pectin. Secondary cell walls, produced after cells cease growth, also contain polysaccharides and are reinforced by the polymer lignin covalently crosslinked to hemicellulose. Cellulose is a homopolymer of anhydrocellobiose, thus a linear beta-(1-4)-D-glucan, while hemicelluloses include various compounds, such as xylans, xyloglucans, arabinoxylans, and mannans, with complex branched structures possessing various substituents. While cellulose is generally polymorphic, in plant tissues it is primarily found as an insoluble crystalline matrix of aligned glucan chains. Hemicellulose typically hydrogen bonds to cellulose and other hemicelluloses, which helps stabilize the cell wall matrix.
[0164] Cellulose is commonly found, for example, in the stems, leaves, husks, husks, and cobs of plants, or the leaves, branches, and wood of trees. Cellulose-containing materials can include, but are not limited to, agricultural residues, herbaceous materials (including energy crops), municipal solid waste, pulp and paper mill residues, waste paper, and wood (including forestry residues) (see, e.g., Wiselogel et al., 1995, in Handbook on Bioethanol (Charles E. Wyman, editor), pp. 105-118, Taylor & Francis, Washington DC; Wyman, 1994, Bioresource Technology 50:3-16; Lynd, 1990, Applied Biochemistry and Biotechnology 24 / 25:695-719; Mosier et al., 1999, Recent Progress in Bioconversion of Lignocellulosics, in Advances in Biochemical Engineering / Biotechnology, T. Scheper, managing editor, Volume 65, pp. 23-40, Springer-Verlag, New York). It is understood herein that cellulose can be in the form of lignocellulose, which is a plant cell wall material containing lignin, cellulose, and hemicellulose in a mixed matrix. In one embodiment, the cellulose-containing material is any biomass material. In another embodiment, the cellulose-containing material is lignocellulose, which includes cellulose, hemicellulose, and lignin.
[0165] In one embodiment, the cellulose-containing material is agricultural waste, herbaceous material (including energy crops), municipal solid waste, pulp and paper mill waste, waste paper, or wood (including forestry residues).
[0166] In another embodiment, the cellulose-containing material is arundo, bagasse, bamboo, corn cob, corn fiber, corn stover, miscanthus, rice straw, switchgrass, or wheat stalk.
[0167] In another embodiment, the cellulose-containing material is poplar, eucalyptus, fir, pine, aspen, spruce, or willow.
[0168] In another embodiment, the cellulose-containing material is algal cellulose, bacterial cellulose, cotton linters, filter paper, crystalline cellulose (eg, AVICEL®), or phosphoric acid-treated cellulose.
[0169] In another embodiment, the cellulose-containing material is aquatic biomass. As used herein, the term "aquatic biomass" refers to biomass produced in an aquatic environment by the process of photosynthesis. The aquatic biomass can be algae, emerged plants, floating plants, or submerged plants.
[0170] The cellulose-containing material can be used as is or can be subjected to pretreatment using conventional methods known in the art, as described herein. In a preferred embodiment, the cellulose-containing material is pretreated.
[0171] The method of using cellulose-containing materials can be accomplished using methods conventional in the art. Additionally, the method can be carried out using any conventional biomass processing equipment configured to carry out the process.
[0172] Cellulose Pretreatment In one embodiment, the cellulose-containing material is pretreated prior to saccharification.
[0173] In practicing the processes described herein, any pretreatment process known in the art can be used to disrupt the plant cell wall components of cellulose-containing materials (Chandra et al., 2007, Adv. Biochem. Engin. / Biotechnol. 108:67-93; Galbe and Zacchi, 2007, Adv. Biochem. Engin. / Biotechnol. 108:41-65; Hendriks and Zeeman, 2009, Bioresource Technology 100:10-18; Mosier et al., 2005, Bioresource Technology 96:673-686; Taherzadeh and Karimi, 2008, Int. J. Mol. Sci. 9:1621-1651; Yang and Wyman, 2008, Biofuels Bioproducts and Biorefining-Biofpr. 2;26-40).
[0174] The cellulose-containing material may also be subjected to particle size reduction, sieving, pre-soaking, wetting, washing, and / or conditioning prior to pre-treatment using methods known in the art.
[0175] Conventional pretreatments include, but are not limited to, steam pretreatment (with or without explosion), dilute acid pretreatment, hot water pretreatment, alkali pretreatment, lime pretreatment, wet oxidation, wet explosion, ammonia fiber explosion, organosolv pretreatment, and biological pretreatment. Additional pretreatments include ammonia percolation, ultrasound, electroporation, microwave, supercritical CO, supercritical H, ozone, ionic liquids, and gamma irradiation pretreatment.
[0176] In one embodiment, the cellulose-containing material is pretreated prior to saccharification (i.e., hydrolysis) and / or fermentation. Pretreatment is preferably carried out prior to hydrolysis. Alternatively, pretreatment can be carried out simultaneously with enzymatic hydrolysis to release fermentable sugars such as glucose, xylose, and / or cellobiose. In most cases, the pretreatment step itself (even in the absence of enzymes) results in some conversion of biomass to fermentable sugars.
[0177] In one embodiment, the cellulose-containing material is pretreated with steam. In steam pretreatment, the cellulose-containing material is heated to break down plant cell wall components, including lignin, hemicellulose, and cellulose, making the cellulose and other fractions, such as hemicellulose, accessible to enzymes. The cellulose-containing material is passed through a reaction vessel where steam is injected to raise the temperature to the required temperature and pressure and maintained for the desired reaction time. Steam pretreatment is preferably carried out at 140-250°C, e.g., 160-200°C or 170-190°C, with the optimal temperature range depending on the optional addition of a chemical catalyst. The residence time for steam pretreatment is preferably 1-60 minutes, e.g., 1-30 minutes, 1-20 minutes, 3-12 minutes, or 4-10 minutes, with the optimal residence time depending on the temperature and the optional addition of a chemical catalyst. Because steam pretreatment allows for relatively high solids loading, the cellulose-containing material generally only remains wet during pretreatment. Steam pretreatment is often combined with the explosive release of the pretreated material, known as steam explosion, i.e., rapid flushing to atmospheric pressure and turbulent flow of the material to increase the accessible surface area through fragmentation (Duff and Murray, 1996, Bioresource Technology 855:1-33; Galbe and Zacchi, 2002, Appl. Microbiol. Biotechnol. 59:618-628; U.S. Patent Application Publication No. 2002 / 0164730). During steam pretreatment, hemicellulose acetyl groups are cleaved, and the resulting acid autocatalyzes the partial hydrolysis of hemicellulose into mono- and oligosaccharides. Lignin is only removed to a limited extent.
[0178] In one embodiment, the cellulose-containing material is subjected to chemical pretreatment. The term "chemical treatment" refers to any chemical pretreatment that promotes the separation and / or release of cellulose, hemicellulose, and / or lignin. Such pretreatment can convert crystalline cellulose to amorphous cellulose. Examples of suitable chemical pretreatment processes include, for example, dilute acid pretreatment, lime pretreatment, wet oxidation, ammonia fiber / freeze explosion (AFEX), ammonia percolation (APR), ionic liquid, and organosolv pretreatment.
[0179] A chemical catalyst such as H2SO4 or SO2 (typically 0.3-5 w / w%) is sometimes added before steam pretreatment, which reduces the time and temperature, increases recovery, and improves enzymatic hydrolysis (Ballesteros et al., 2006, Appl. Biochem. Biotechnol. 129-132:496-508; Varga et al., 2004, Appl. Biochem. Biotechnol. 113-116:509-523; Sassner et al., 2006, Enzyme Microb. Technol. 39:756-762). In dilute acid pretreatment, the cellulose-containing material is mixed with dilute acid, typically H2SO4, and water to form a slurry, which is heated with steam to the desired temperature and, after a residence time, flashed to atmospheric pressure. Dilute acid pretreatment can be carried out in several reactor designs, such as a plug flow reactor, a countercurrent reactor, or a continuous countercurrent contracting bed reactor (Duff and Murray, 1996, Bioresource Technology 855:1-33; Schell et al., 2004, Bioresource Technology 91:179-188; Lee et al., 1999, Adv. Biochem. Eng. Biotechnol. 65:93-115). In certain embodiments, dilute acid pretreatment of cellulose-containing material is carried out using 4 wt.% sulfuric acid at 180°C for 5 minutes.
[0180] Several methods of pretreatment under alkaline conditions can also be used. These alkaline pretreatments include, but are not limited to, sodium hydroxide, lime, wet oxidation, ammonia percolation (APR), and ammonia fiber / freeze explosion (AFEX) pretreatments. Lime pretreatment is carried out with calcium oxide or calcium hydroxide at temperatures between 85 and 150°C and residence times between one hour and several days (Wyman et al., 2005, Bioresource Technology 96:1959-1966; Mosier et al., 2005, Bioresource Technology 96:673-686). WO 2006 / 110891, WO 2006 / 110899, WO 2006 / 110900, and WO 2006 / 110901 disclose pretreatment methods using ammonia.
[0181] Wet oxidation is a thermal pretreatment typically carried out at 180-200°C for 5-15 minutes with the addition of an oxidizing agent such as hydrogen peroxide or with an oxygen overpressure (Schmidt and Thomsen, 1998, Bioresource Technology 64:139-151; Palonen et al., 2004, Appl. Biochem. Biotechnol. 117:1-17; Varga et al., 2004, Biotechnol. Bioeng. 88:567-574; Martin et al., 2006, J. Chem. Technol. Biotechnol. 81:1669-1677). Pretreatment is preferably carried out at 1-40% dry matter, e.g., 2-30% dry matter or 5-20% dry matter, and the initial pH is often raised by the addition of an alkali such as sodium carbonate.
[0182] A modification of the wet oxidation pretreatment method, known as wet explosion (a combination of wet oxidation and steam explosion), can treat up to 30% of the dry material. In wet explosion, an oxidizing agent is introduced during pretreatment after a specific residence time. Pretreatment is then completed by flashing to atmospheric pressure (WO 2006 / 032282).
[0183] Ammonia fiber explosion (AFEX) involves treating cellulose-containing materials with liquid or gaseous ammonia at moderate temperatures, such as 90–150°C, and high pressures, such as 17–20 bar, for 5–10 minutes, resulting in dry matter contents as high as 60% (Gollapalli et al., 2002, Appl. Biochem. Biotechnol. 98:23–35; Chundawat et al., 2007, Biotechnol. Bioeng. 96:219–231; Alizadeh et al., 2005, Appl. Biochem. Biotechnol. 121:1133–1141; Teymouri et al., 2005, Bioresource Technology 96:2014–2018). During AFEX pretreatment, cellulose and hemicellulose remain relatively intact. Lignin-carbohydrate complexes are cleaved.
[0184] Organosolv pretreatment delignifies cellulose-containing materials by extraction with aqueous ethanol (40-60% ethanol) at 160-200°C for 30-60 minutes (Pan et al., 2005, Biotechnol. Bioeng. 90:473-481; Pan et al., 2006, Biotechnol. Bioeng. 94:851-861; Kurabi et al., 2005, Appl. Biochem. Biotechnol. 121:219-230). Sulfuric acid is usually added as a catalyst. In organosolv pretreatment, most of the hemicellulose and lignin are removed.
[0185] Other examples of suitable pretreatment methods are described by Schell et al., 2003, Appl. Biochem. Biotechnol. 105-108:69-85, and Mosier et al., 2005, Bioresource Technology 96:673-686, and U.S. Patent Application Publication No. 2002 / 0164730.
[0186] In one embodiment, the chemical pretreatment is carried out as a dilute acid treatment, more preferably as a continuous dilute acid treatment. The acid is typically sulfuric acid, but other acids such as acetic acid, citric acid, nitric acid, phosphoric acid, tartaric acid, succinic acid, hydrochloric acid, or mixtures thereof can also be used. The weak acid treatment is preferably carried out at a pH range of 1 to 5, e.g., 1 to 4 or 1 to 2.5. In one embodiment, the acid concentration is preferably in the range of 0.01 to 10 wt% acid, e.g., 0.05 to 5 wt% acid, or 0.1 to 2 wt% acid. The acid is maintained in contact with the cellulose-containing material at a temperature preferably in the range of 140 to 200°C, e.g., 165 to 190°C, for a period ranging from 1 to 60 minutes.
[0187] In another embodiment, the pretreatment is carried out in an aqueous slurry. In a preferred embodiment, the cellulose-containing material is present during the pretreatment in an amount of preferably 10 to 80 wt%, for example, 20 to 70 wt%, or 30 to 60 wt%, for example, approximately 40 wt%. The pretreated cellulose-containing material may be unwashed or may be washed using any method known in the art, for example, with water.
[0188] In one embodiment, the cellulose-containing material is subjected to mechanical or physical pretreatment. The terms "mechanical pretreatment" or "physical pretreatment" refer to any pretreatment that promotes particle size reduction. For example, such pretreatment can include various types of milling or grinding (e.g., dry milling, wet milling, or vibratory ball milling).
[0189] Cellulose-containing materials can be pretreated both physically (mechanically) and chemically. Mechanical or physical pretreatment can be coupled with steam explosion, hydrothermal decomposition, dilute or weak acid treatment, high temperature, high pressure treatment, irradiation (e.g., microwave irradiation), or a combination thereof. In one embodiment, high pressure refers to a pressure preferably in the range of about 100 to about 400 psi, e.g., about 150 to about 250 psi. In another embodiment, high temperature refers to a temperature in the range of about 100 to about 300°C, e.g., about 140 to about 200°C. In a preferred embodiment, mechanical or physical pretreatment is carried out in a batch process using a steam gun hydrolyzer system employing high pressure and high temperature as defined above, e.g., a Sunds hydrolyzer available from Sunds Defibrator AB, Sweden. Physical and chemical pretreatments can be carried out sequentially or simultaneously, if desired.
[0190] Thus, in one embodiment, the cellulose-containing material is subjected to a physical (mechanical) or chemical pretreatment, or any combination thereof, to facilitate the separation and / or release of cellulose, hemicellulose, and / or lignin.
[0191] In one embodiment, the cellulose-containing material is subjected to biological pretreatment. The term "biological pretreatment" refers to any biological pretreatment that promotes the separation and / or release of cellulose, hemicellulose, and / or lignin from the cellulose-containing material. Biological pretreatment techniques can include using lignin-solubilizing microorganisms and / or enzymes (e.g., Hsu, T.-A., 1996, Pretreatment of biomass, Handbook on Bioethanol: Production and Utilization, Wyman, C.E., ed., Taylor & Francis, Washington, DC, 179-212; Ghosh and Singh, 1993, Adv. Appl. Microbiol. 39:295-333; McMillan, J.D., 1994, Pretreating lignocellulosic biomass: a review, in Enzymatic Conversion of Biomass for Fuels Production, Himmel, M.E., Baker, J.O., and Overend, R.P., eds., ACS Symposium Series 566, American Chemical Society, Washington, DC, chapter 15; Gong, C.S., Cao, N.J., Du, J., and Tsao, GT, 1999, Ethanol production from renewable resources, in Advances in Biochemical Engineering / Biotechnology, Scheper, T., ed., Springer-Verlag Berlin Heidelberg, Germany, 65:207-241; Olsson and Hahn-Hagerdal, 1996, Enz. Microb. Tech. 18: 312-331; and Vallander and (See Eriksson, 1990, Adv.Biochem.Eng. / Biotechnol.42:63-95).
[0192] Saccharification and fermentation of cellulose-containing materials Separate or simultaneous saccharification (i.e., hydrolysis) and fermentation include, but are not limited to, separate hydrolysis and fermentation (SHF); simultaneous saccharification and fermentation (SSF); simultaneous saccharification and co-fermentation (SSCF); combined hydrolysis and fermentation (HHF); separate hydrolysis and co-fermentation (SHCF); and combined hydrolysis and co-fermentation (HHCF).
[0193] SHF uses separate process steps to first enzymatically hydrolyze cellulose-containing materials into fermentable sugars, such as glucose, cellobiose, and pentose monomers, and then ferment the fermentable sugars to ethanol. In SSF, the enzymatic hydrolysis of cellulose-containing materials and the fermentation of the sugars to ethanol are combined into one process (Philippidis, GP, 1996, Cellulose bioconversion technology, in Handbook on Bioethanol: Production and Utilization, Wyman, CE, ed., Taylor & Francis, Washington, DC, 179-212). SSCF involves the co-fermentation of multiple sugars (Sheehan and Himmel, 1999, Biotechnol. Prog. 15:817-827). HHF involves separate hydrolysis steps, plus simultaneous saccharification and hydrolysis steps, which can be carried out in the same reactor. The steps in the HHF process can be carried out at different temperatures (i.e., high temperature enzymatic saccharification followed by SSF at a lower temperature tolerated by the fermenting organisms). It is understood herein that any method known in the art, including pretreatment, enzymatic hydrolysis (saccharification), fermentation, or a combination thereof, can be used in practicing the processes described herein.
[0194] Conventional equipment can include fed-batch stirred reactors, batch stirred reactors, continuous flow stirred reactors with ultrafiltration, and / or continuous plug flow column reactors (de Castilhos Corazza et al., 2003, Acta Scientiarum. Technology 25:33-38; Gusakov and Sinitsyn, 1985, Enz. Microb. Technol. 7:346-352), attrition reactors (Ryu and Lee, 1983, Biotechnol. Bioeng. 25:53-65). Additional reactor types include fluidized bed, upflow blanket, immobilized, and extruder-type reactors for hydrolysis and / or fermentation.
[0195] In the saccharification process (i.e., hydrolysis process), e.g., pretreated, cellulose- and / or starch-containing material is hydrolyzed to break down the cellulose, hemicellulose, and / or starch into fermentable sugars such as glucose, cellobiose, xylose, xylulose, arabinose, mannose, galactose, and / or soluble oligosaccharides. Hydrolysis is carried out enzymatically, e.g., by a cellulolytic enzyme composition. The enzymes of the composition can be added simultaneously or sequentially.
[0196] Enzymatic hydrolysis can be carried out in a suitable aqueous environment under conditions that can be easily determined by one skilled in the art. In one embodiment, the hydrolysis is carried out under conditions that are suitable for the activity of the enzyme, i.e., optimal for the enzyme. The hydrolysis can be carried out as a fed-batch or continuous process, in which the cellulose- and / or starch-containing material is gradually fed, for example, to an enzyme-containing hydrolysis solution.
[0197] Saccharification is generally carried out in a stirred tank reactor or fermenter under controlled pH, temperature, and mixing conditions. Appropriate process time, temperature, and pH conditions can be readily determined by those skilled in the art. For example, saccharification can last up to 200 hours, but is typically carried out for about 12 to about 120 hours, e.g., about 16 to 72 hours or about 24 to 48 hours. The temperature is preferably within the range of about 25°C to about 70°C, e.g., about 30°C to about 65°C, about 40°C to about 60°C, or about 50°C to about 55°C. The pH is preferably within the range of about 3 to about 8, e.g., about 3.5 to about 7, about 4 to about 6, or about 4.5 to about 5.5. The dry solids content is preferably within the range of about 5 to about 50 wt%, e.g., about 10 to about 40 wt%, or about 20 to about 30 wt%.
[0198] Saccharification can be carried out using a cellulolytic enzyme composition. Such enzyme compositions are described below in the section "Cellulolytic Enzyme Compositions." The cellulolytic enzyme composition can include any protein useful for degrading cellulose-containing materials. In one embodiment, the cellulolytic enzyme composition includes, or further includes, one or more (e.g., several) proteins selected from the group consisting of cellulases, AA9 (GH61) polypeptides, hemicellulases, esterases, expansins, ligninolytic enzymes, oxidoreductases, pectinases, proteases, and swollenins.
[0199] In another embodiment, the cellulase is preferably one or more (eg, several) enzymes selected from the group consisting of endoglucanases, cellobiohydrolases, and beta-glucosidases.
[0200] In another embodiment, the hemicellulase is preferably one or more (e.g., several) enzymes selected from the group consisting of acetylmannan esterase, acetyl xylan esterase, arabinanase, arabinofuranosidase, coumaric acid esterase, feruloyl esterase, galactosidase, glucuronidase, glucuronoyl esterase, mannanase, mannosidase, xylanase, and xylosidase. In another embodiment, the oxidoreductase is one or more (e.g., several) enzymes selected from the group consisting of catalase, laccase, and peroxidase.
[0201] The enzymes or enzyme compositions used in the processes of the invention can be in any form suitable for use, such as a fermentation broth blend or cell composition, a cell lysate with or without cell debris, a semi-purified or purified enzyme preparation, or host cells as the source of enzyme. The enzyme composition can be a dry powder or granule, a non-dusty granule, a liquid, a stabilized liquid, or a stabilized protected enzyme. Liquid enzyme preparations can be stabilized by adding stabilizers such as, for example, a sugar, a sugar alcohol, or another polyol, and / or lactic acid or another organic acid according to established processes.
[0202] In one embodiment, the effective amount of the cellulolytic or hemicellulose-degrading enzyme composition for a cellulose-containing material is about 0.5 to about 50 mg, e.g., about 0.5 to about 40 mg, about 0.5 to about 25 mg, about 0.75 to about 20 mg, about 0.75 to about 15 mg, about 0.5 to about 10 mg, or about 2.5 to about 10 mg per gram of cellulose-containing material.
[0203] In one embodiment, such compounds are present in a molar ratio of compound to glucosyl units of cellulose of about 10 -6 to about 10, e.g., about 10 -6 vs. about 7.5, about 10 -6 vs. about 5, about 10 -6 to about 2.5, about 10 -6 to about 1, about 10 -5 to about 1, about 10 -5 to about 10-1 , about 10 -4 to about 10 -1 , about 10 -3 to about 10 -1 , or about 10 -3 to about 10 -2 In another embodiment, the effective amount of such a compound is about 0.1 μM to about 1 M, e.g., about 0.5 μM to about 0.75 M, about 0.75 μM to about 0.5 M, about 1 μM to about 0.25 M, about 1 μM to about 0.1 M, about 5 μM to about 50 mM, about 10 μM to about 25 mM, about 50 μM to about 25 mM, about 10 μM to about 10 mM, about 5 μM to about 5 mM, or about 0.1 mM to about 1 mM.
[0204] The term "liquid" refers to the aqueous, organic, or combination of solution phases and their soluble contents resulting from the processing of lignocellulosic and / or hemicellulosic materials in a slurry, or their monosaccharides, e.g., xylose, arabinose, mannose, etc., under conditions such as those described in WO 2012 / 021401. A liquid for AA9 polypeptide (GH61 polypeptide) cellulolytic enhancement can be produced by treating lignocellulosic or hemicellulosic materials (or feedstocks) with heat and / or pressure, optionally in the presence of a catalyst, e.g., an acid, optionally in the presence of an organic solvent, and optionally in combination with physical disruption of the material, followed by separation of the liquid from the residual solids. Such conditions determine the degree of cellulolytic enhancement obtainable via the combination of the liquid and the AA9 polypeptide during hydrolysis of the cellulosic substrate with the cellulolytic enzyme preparation. The liquid can be separated from the treated material using methods standard in the art, such as filtration, sedimentation, or centrifugation.
[0205] In one embodiment, the effective amount of liquid relative to the cellulose is about 10g of cellulose per gram of cellulose. -6 ~ about 10 g, e.g., about 10 per gram of cellulose -6 ~Approx. 7.5g, approx. 10 -6 ~about 5g, about 10 -6 ~Approx. 2.5g, approx. 10 -6 ~approx. 1g, approx. 10-5 ~approx. 1g, approx. 10 -5 ~about 10 -1 g, about 10 -4 ~about 10 -1 g, about 10 -3 ~about 10 -1 g, or about 10 -3 ~about 10 -2 g.
[0206] In the fermentation process, sugars released from the cellulose-containing material, for example as a result of the pretreatment and enzymatic hydrolysis steps, are fermented to ethanol by a fermenting organism, such as a yeast, as described herein. Hydrolysis (saccharification) and fermentation can be separate or simultaneous.
[0207] Any suitable hydrolyzed cellulose-containing material can be used in the fermentation step in practicing the processes described herein. Such feedstocks include, but are not limited to, carbohydrates (e.g., lignocellulose, xylan, cellulose, starch, etc.). Materials are generally selected based on economics, i.e., cost per equivalent sugar potential, and resistance to enzymatic conversion.
[0208] The production of ethanol by fermenting organisms using cellulose-containing materials results from the metabolism of sugars (monosaccharides). The sugar composition of the hydrolyzed cellulose-containing material and the ability of the fermenting organism to utilize different sugars has a direct impact on the process yield.
[0209] The composition of the fermentation medium and fermentation conditions depend on the fermenting organism and can be easily determined by one skilled in the art. Typically, fermentation is carried out under conditions known to be suitable for producing a fermentation product. In some embodiments, the fermentation process is carried out under aerobic or microaerobic (i.e., the concentration of oxygen is less than that in air) or anaerobic conditions. In some embodiments, fermentation is carried out under anaerobic conditions (i.e., no detectable oxygen) or at less than about 5, about 2.5, or about 1 mmol / L / h oxygen. In the absence of oxygen, NADH produced in glycolysis cannot be oxidized by oxidative phosphorylation. Under anaerobic conditions, pyruvate or a derivative thereof can be utilized by the fermenting organism as an electron and hydrogen acceptor to produce NAD+.
[0210] The fermentation process is typically carried out at a temperature that is optimal for the cells. For example, in some embodiments, the fermentation process is carried out at a temperature within the range of about 25° C. to about 42° C. Typically, the process is carried out at a temperature of less than about 38° C., less than about 35° C., less than about 33° C., or less than 38° C., but at least about 20° C., 22° C., or 25° C.
[0211] Fermentation stimulators can be used in the processes described herein to further improve fermentation and the performance of fermenting organisms, particularly rate enhancement and product yield (e.g., ethanol yield). "Fermentation stimulator" refers to a stimulator for the growth of fermenting organisms, particularly yeast. Preferred fermentation stimulators for growth include vitamins and minerals. Examples of vitamins include multivitamins, biotin, pantothenate, nicotinic acid, meso-inositol, thiamine, pyridoxine, para-aminobenzoic acid, folic acid, riboflavin, and vitamins A, B, C, D, and E. See, for example, Alfenore et al., "Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during a fed-batch process," Springer-Verlag (2002), incorporated herein by reference. Examples of minerals include minerals and mineral salts that can provide nutrients, including P, K, Mg, S, Ca, Fe, Zn, Mn, and Cu.
[0212] Cellulolytic enzymes and compositions Cellulolytic enzymes or cellulolytic enzyme compositions can be present and / or added during saccharification. Cellulolytic enzyme compositions are enzyme preparations containing one or more (e.g., several) enzymes that hydrolyze cellulose-containing materials. Such enzymes can include endoglucanases, cellobiohydrolases, beta-glucosidases, or combinations thereof.
[0213] In some embodiments, the fermenting organism comprises one or more (e.g., several) heterologous polynucleotides encoding enzymes that hydrolyze cellulose-containing material (e.g., endoglucanases, cellobiohydrolases, beta-glucosidases, or combinations thereof). Any enzyme described or referenced herein that hydrolyzes cellulose-containing material is contemplated for expression in the fermenting organism.
[0214] The cellulolytic enzyme can be any cellulolytic enzyme (e.g., endoglucanase, cellobiohydrolase, beta-glucosidase) suitable for expression in the fermentation organisms and / or methods described herein, such as a naturally occurring cellulolytic enzyme or a variant thereof that retains cellulolytic enzyme activity.
[0215] In some embodiments, a fermenting organism comprising a heterologous polynucleotide encoding a cellulolytic enzyme has an increased level of cellulolytic enzyme activity (e.g., increased endoglucanase, cellobiohydrolase, and / or beta-glucosidase) when cultured under the same conditions, compared to a fermenting organism lacking a heterologous polynucleotide encoding a cellulolytic enzyme. In some embodiments, the fermenting organism has an increased level of cellulolytic enzyme activity by at least 5%, e.g., at least 10%, at least 15%, at least 20%, at least 25%, at least 50%, at least 100%, at least 150%, at least 200%, at least 300%, or at least 500%, when cultured under the same conditions, compared to a fermenting organism lacking a heterologous polynucleotide encoding a cellulolytic enzyme.
[0216] Exemplary cellulolytic enzymes that can be used in the fermentation organisms and / or methods described herein include bacterial, yeast, or filamentous fungal cellulolytic enzymes obtained from any of the microorganisms described or referenced herein, e.g., as described supra under the section on proteases.
[0217] The cellulolytic enzyme may be of any origin. In one embodiment, the cellulolytic enzyme is derived from a strain of the genus Trichoderma, such as a strain of Trichoderma reesei; a strain of the genus Humicola, such as a strain of Humicola insolens, and / or a strain of the genus Chrysosporium, such as a strain of Chrysosporium lucknowense. In a preferred embodiment, the cellulolytic enzyme is derived from a strain of Trichoderma reesei.
[0218] The cellulolytic enzyme composition can further include one or more of the following polypeptides, such as enzymes: an AA9 polypeptide (GH61 polypeptide) having cellulolytic enhancing activity, a beta-glucosidase, a xylanase, a beta-xylosidase, a CBH I, a CBH II, or a mixture of two, three, four, five, or six of these.
[0219] The additional polypeptides (e.g., AA9 polypeptides) and / or enzymes (e.g., beta-glucosidase, xylanase, beta-xylosidase, CBH I, and / or CBH II) may be exogenous to the cellulolytic enzyme composition producing organism (e.g., Trichoderma reesei).
[0220] In one embodiment, the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity and a beta-glucosidase.
[0221] In another embodiment, the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity, a beta-glucosidase, and a CBH I.
[0222] In another embodiment, the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity, a beta-glucosidase, CBH I, and CBH II. Other enzymes, such as endoglucanases, can also be included in the cellulolytic enzyme composition.
[0223] As noted above, the cellulolytic enzyme composition can include several different polypeptides that comprise the enzyme.
[0224] In one embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a Thermoascus aurantiacus AA9 (GH61A) polypeptide (e.g., WO 2008 / 074656) and an Aspergillus oryzae beta-glucosidase fusion protein (e.g., as disclosed in WO 2005 / 057637, particularly as set forth as SEQ ID NOs: 59 and 60) having cellulolytic enhancing activity.
[0225] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising a Thermoascus aurantiacus AA9 (GH61A) polypeptide (e.g., SEQ ID NO: 2 in WO 2005 / 074656) having cellulolytic enhancing activity and an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499).
[0226] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly as disclosed in WO 2011 / 041397, and an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WO 2005 / 047499).
[0227] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly as disclosed in WO 2011 / 041397, and an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WO 2012 / 047499) or a variant disclosed in WO 2005 / 044915 (incorporated herein by reference), particularly one comprising one or more, such as all of the following substitutions: F100D, S283G, N456E, F512Y.
[0228] In one embodiment, the cellulolytic enzyme composition comprises an AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly one derived from a strain of Penicillium emersonii (e.g., SEQ ID NO: 2 in WO 2011 / 041397), an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2012 / 047499) variant having one or more, particularly all, of the following substitutions: F100D, S283G, N456E, F512Y, and disclosed in WO 2012 / 044915; an Aspergillus fumigatus Cel7A variant having one or more, particularly all, of the following substitutions: F100D, S283G, N456E, F512Y; CBH1, e.g., as disclosed in WO 2011 / 057140 as SEQ ID NO: 6, and Aspergillus fumigatus CBH II, e.g., as disclosed in WO 2011 / 057140 as SEQ ID NO: 18.
[0229] In a preferred embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a hemicellulase or hemicellulolytic enzyme composition, such as an Aspergillus fumigatus xylanase and an Aspergillus fumigatus beta-xylosidase.
[0230] Also, in one embodiment, the cellulolytic enzyme composition comprises a xylanase (e.g., from a strain of the genus Aspergillus, particularly Aspergillus aculeatus or Aspergillus fumigatus; or from a strain of the genus Talaromyces, particularly Talaromyces leycettanus) and / or a beta-xylosidase (e.g., from a strain of the genus Aspergillus, particularly Aspergillus fumigatus, or from a strain of the genus Talaromyces, particularly Talaromyces emersonii).
[0231] In one embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a Thermoascus aurantiacus AA9 (GH61A) polypeptide having cellulolytic enhancing activity (e.g., WO 2005 / 074656), an Aspergillus oryzae beta-glucosidase fusion protein (e.g., as disclosed in WO 2008 / 057637, particularly as SEQ ID NOS: 59 and 60), and an Aspergillus aculetus xylanase (e.g., Xyl II in WO 94 / 21785).
[0232] In another embodiment, the cellulolytic enzyme composition comprises a Trichoderma reesei cellulolytic enzyme preparation further comprising a Thermoascus aurantiacus GH61A polypeptide (e.g., SEQ ID NO: 2 in WO 2005 / 074656) having cellulolytic enhancing activity, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499), and an Aspergillus aculetus xylanase (e.g., Xyl II as disclosed in WO 94 / 21785).
[0233] In another embodiment, the cellulolytic enzyme composition comprises a Trichoderma reesei cellulolytic enzyme composition further comprising a Thermoascus aurantiacus AA9 (GH61A) polypeptide (e.g., SEQ ID NO: 2 in WO 2005 / 074656) having cellulolytic enhancing activity, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499), and an Aspergillus aculetus xylanase (e.g., Xyl II as disclosed in WO 94 / 21785).
[0234] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition further comprising a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly one disclosed in WO 2011 / 041397, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499), and an Aspergillus fumigatus xylanase (e.g., Xyl III in WO 2006 / 078256).
[0235] In another embodiment, the cellulolytic enzyme composition is a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly as disclosed in WO 2011 / 041397, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499), an Aspergillus fumigatus xylanase (e.g., Xyl III in WO 2006 / 078256), and a Trichoderma reesei CBH I from Aspergillus fumigatus, particularly the Cel7A CBH1 disclosed as SEQ ID NO: 2 in WO 2011 / 057140. reesei) cellulolytic enzyme composition.
[0236] In another embodiment, the cellulolytic enzyme composition includes a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly that disclosed in WO 2011 / 041397, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499), an Aspergillus fumigatus xylanase (e.g., Xyl III in WO 2006 / 078256), a CBH I from Aspergillus fumigatus, particularly Cel7A CBH1 disclosed as SEQ ID NO: 2 in WO 2011 / 057140, and an Aspergillus fumigatus CBH II. The present invention relates to a Trichoderma reesei cellulolytic enzyme composition, which further comprises CBH II derived from Trichoderma fumigatus, particularly that disclosed as SEQ ID NO: 4 in WO 2013 / 028928.
[0237] In another embodiment, the cellulolytic enzyme composition comprises a Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, particularly as disclosed in WO 2011 / 041397, an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WO 2005 / 047499) or a variant thereof having one or more, particularly all of the following substitutions: F100D, S283G, N456E, F512Y; an Aspergillus fumigatus xylanase (e.g., Xyl III in WO 2006 / 078256), a CBH from Aspergillus fumigatus, or a CBH from Aspergillus fumigatus. and a CBH II from Aspergillus fumigatus, particularly as disclosed in WO 2013 / 028928.
[0238] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising CBH I (GENSEQP Accession No. AZY49536 (WO 2012 / 103293)); CBH II (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)); beta-glucosidase variant (GENSEQP Accession No. AZU67153 (WO 2012 / 44915)) (particularly having one or more, particularly all, of the following substitutions: F100D, S283G, N456E, F512Y); and AA9 (GH61 polypeptide) (GENSEQP Accession No. BAL61510 (WO 2013 / 028912)).
[0239] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising CBH I (GENSEQP Accession No. AZY49536 (WO 2012 / 103293)); CBH II (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)); GH10 xylanase (GENSEQP Accession No. BAK46118 (WO 2013 / 019827)); and beta-xylosidase (GENSEQP Accession No. AZI04896 (WO 2011 / 057140)).
[0240] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising CBH I (GENSEQP Accession No. AZY49536 (WO 2012 / 103293)); CBH II (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)); and AA9 (GH61 polypeptide; GENSEQ Accession No. BAL61510 (WO 2013 / 028912)).
[0241] In another embodiment, the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising CBH I (GENSEQP Accession No. AZY49536 (WO 2012 / 103293)); CBH II (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)), AA9 (GH61 polypeptide; GENSEQP Accession No. BAL61510 (WO 2013 / 028912)), and catalase (GENSEQP Accession No. BAC11005 (WO 2012 / 130120)).
[0242] In one embodiment, the cellulolytic enzyme composition comprises a CBH I (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)); a CBH II (GENSEQP Accession No. AZY49446 (WO 2012 / 103288)), a beta-glucosidase variant (GENSEQP Accession No. AZU67153 (WO 2012 / 44915)) (having one or more, particularly all of the following substitutions: F100D, S283G, N456E, F512Y); an AA9 (GH61 polypeptide; GENSEQP Accession No. AZU67153 (WO 2012 / 44915)) (having one or more, particularly all, of the following substitutions: F100D, S283G, N456E, F512Y); A Trichoderma reesei cellulolytic enzyme composition comprising Trichoderma reesei cellulolytic enzymes (accession number BAL61510 (WO 2013 / 028912)), GH10 xylanase (GENSEQP accession number BAK46118 (WO 2013 / 019827)), and beta-xylosidase (GENSEQP accession number AZI04896 (WO 2011 / 057140)).
[0243] In one embodiment, the cellulolytic composition is a Trichoderma reesei cellulolytic enzyme preparation comprising EG I (Swissprot Accession No. P07981), EG II (EMBL Accession No. M19373), CBH I (supra); CBH II (supra); beta-glucosidase variant (supra) (having the following substitutions: F100D, S283G, N456E, F512Y); AA9 (GH61 polypeptide; supra), GH10 xylanase (supra); and beta-xylosidase (supra).
[0244] Also contemplated are all cellulolytic enzyme compositions disclosed in WO 2013 / 028928, which are incorporated herein by reference.
[0245] The cellulolytic enzyme composition may comprise or further comprise one or more (several) proteins selected from the group consisting of cellulases, AA9 (i.e., GH61) polypeptides with cellulolytic enhancing activity, hemicellulases, expansins, esterases, laccases, ligninolytic enzymes, pectinases, peroxidases, proteases, and swollenins.
[0246] In one embodiment, the cellulolytic enzyme composition is a commercially available cellulolytic enzyme composition. Examples of commercially available cellulolytic enzyme compositions suitable for use in the process of the present invention include: CELLIC® CTec (Novozymes A / S), CELLIC® CTec2 (Novozymes A / S), CELLIC® CTec3 (Novozymes A / S), CELLUCLAST™ (Novozymes A / S), SPEZYME™ CP (Genencor Int.), ACCELLERASE™ 1000, ACCELLERASE™ 1500, ACCELLERASE™ TRIO (DuPont), FILTRASE® NL (DSM); METHAPLUS® S / L 100 (DSM), ROHAMENT™ 7069 W (Roehm GmbH), or ALTERNAFUEL® CMAX3™ (Dyadic International, Inc.). The cellulolytic enzyme composition can be added in an effective amount of about 0.001 to about 5.0 wt% solids, for example, about 0.025 to about 4.0 wt% solids or about 0.005 to about 2.0 wt% solids.
[0247] Additional enzymes and compositions thereof can be found in WO 2016 / 153516 and WO 2011 / 045569, the contents of which are incorporated herein.
[0248] Additional polynucleotides encoding suitable cellulolytic enzymes can be obtained from microorganisms of any genus, including those readily available within the UniProtKB database (www.uniprot.org).
[0249] Cellulolytic enzyme coding sequences can also be used to design nucleic acid probes for identifying and cloning DNA encoding cellulolytic enzymes from strains of different genera or species known in the art.
[0250] Polynucleotides encoding cellulolytic enzymes can also be identified and obtained from microorganisms isolated from nature (e.g., soil, compost, water, etc.) or from other sources known in the art, including DNA samples obtained directly from natural materials (e.g., soil, compost, water, etc.).
[0251] Techniques used to isolate or clone polynucleotides encoding cellulolytic enzymes are known in the art.
[0252] In one embodiment, the cellulolytic enzyme has a mature polypeptide sequence that is at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identical to any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase). In one embodiment, the cellulolytic enzyme has a mature polypeptide sequence that differs from any cellulolytic enzyme described or referenced herein by 10 or fewer amino acids, e.g., by 5 or fewer amino acids, 4 or fewer amino acids, 3 or fewer amino acids, 2 or fewer amino acids, or 1 amino acid. In one embodiment, the cellulolytic enzyme has a mature polypeptide sequence that comprises or consists of the amino acid sequence of any cellulolytic enzyme, allelic variant, or fragment thereof having cellulolytic enzyme activity described or referenced herein. In one embodiment, the cellulolytic enzyme has one or more (e.g., two, several) amino acid substitutions, deletions, and / or insertions. In some embodiments, the total number of amino acid substitutions, deletions, and / or insertions is 10 or less, e.g., 9 or less, 8, 7, 6, 5, 4, 3, 2, or 1.
[0253] In some embodiments, the cellulolytic enzyme has at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the cellulolytic enzyme activity of any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase) under the same conditions.
[0254] In one embodiment, the cellulolytic enzyme coding sequence hybridizes to the full-length complement of a coding sequence from any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase) under at least low stringency conditions, e.g., under medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions. In one embodiment, the cellulolytic enzyme coding sequence has at least 65%, e.g., at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to a coding sequence from any cellulolytic enzyme described or referenced herein.
[0255] In one embodiment, the polynucleotide encoding the cellulolytic enzyme comprises the coding sequence of any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase). In one embodiment, the polynucleotide encoding the cellulolytic enzyme comprises a subsequence of a coding sequence from any cellulolytic enzyme described or referenced herein, where the subsequence encodes a polypeptide having cellulolytic enzyme activity. In one embodiment, the number of nucleotide residues in the subsequence is at least 75%, e.g., at least 80%, 85%, 90%, or 95%, of the number in the reference coding sequence.
[0256] The cellulolytic enzyme may also comprise a fusion polypeptide or a cleavable fusion polypeptide.
[0257] fermentation products The fermentation product can be any substance resulting from fermentation, including, but not limited to, alcohols (e.g., arabinitol, n-butanol, isobutanol, ethanol, glycerol, methanol, ethylene glycol, 1,3-propanediol [propylene glycol], butanediol, glycerin, sorbitol, and xylitol); alkanes (e.g., pentane, hexane, heptane, octane, nonane, decane, undecane, and dodecane); cycloalkanes (e.g., cyclopentane, cyclohexane, cycloheptane, and cyclooctane); alkenes (e.g., pentene, hexene, heptene, and octene); amino acids (e.g., methylamino acids ... Acids (e.g., aspartic acid, glutamic acid, glycine, lysine, serine, and threonine); gases (e.g., methane, hydrogen (H), carbon dioxide (CO), and carbon monoxide (CO)); isoprene; ketones (e.g., acetone); organic acids (e.g., acetic acid, acetone, adipic acid, ascorbic acid, citric acid, 2,5-diketo-D-gluconic acid, formic acid, fumaric acid, glucaric acid, gluconic acid, glucuronic acid, glutaric acid, 3-hydroxypropionic acid, itaconic acid, lactic acid, malic acid, malonic acid, oxalic acid, oxaloacetic acid, propionic acid, succinic acid, and xylonic acid); and polyketides.
[0258] In one embodiment, the fermentation product is an alcohol. The term "alcohol" encompasses substances containing one or more hydroxyl moieties. Alcohols can include, but are not limited to, n-butanol, isobutanol, ethanol, methanol, arabinitol, butanediol, ethylene glycol, glycerin, glycerol, 1,3-propanediol, sorbitol, and xylitol. See, for example, Gong et al., 1999, Ethanol production from renewable resources, in Advances in Biochemical Engineering / Biotechnology, Scheper, T., ed., Springer-Verlag Berlin Heidelberg, Germany, 65:207-241; Silveira and Jonas, 2002, Appl. Microbiol. Biotechnol. 59:400-408; Nigam and Singh, 1995, Process Biochemistry 30(2):117-124; Ezeji et al., 2003, World Journal of Microbiology and Biotechnology 19(6):595-603. In one embodiment, the fermentation product is ethanol.
[0259] In another embodiment, the fermentation product is an alkane. The alkane can be an unbranched or branched alkane. The alkane can be, but is not limited to, pentane, hexane, heptane, octane, nonane, decane, undecane, or dodecane.
[0260] In another embodiment, the fermentation product is a cycloalkane, which may include, but is not limited to, cyclopentane, cyclohexane, cycloheptane, or cyclooctane.
[0261] In another embodiment, the fermentation product is an alkane. The alkene can be an unbranched or branched alkene. The alkane ene can be, but is not limited to, pentene, hexene, heptene, or octene.
[0262] In another embodiment, the fermentation product is an amino acid. The organic acid may be, but is not limited to, aspartic acid, glutamic acid, glycine, lysine, serine, or threonine. See, e.g., Richard and Margaritis, 2004, Biotechnology and Bioengineering 87(4):501-515.
[0263] In another embodiment, the fermentation product is a gas, which may include, but is not limited to, methane, H, CO, or CO. See, e.g., Kataoka et al., 1997, Water Science and Technology 36(6-7):41-47; and Gunaseelan, 1997, Biomass and Bioenergy 13(1-2):83-114.
[0264] In another embodiment, the fermentation product is isoprene.
[0265] In another embodiment, the fermentation product is a ketone. The term "ketone" encompasses substances containing one or more ketone moieties. Ketones can include, but are not limited to, acetone.
[0266] In another embodiment, the fermentation product is an organic acid, which may include, but is not limited to, acetic acid, acetonic acid, adipic acid, ascorbic acid, citric acid, 2,5-diketo-D-gluconic acid, formic acid, fumaric acid, glucaric acid, gluconic acid, glucuronic acid, glutaric acid, 3-hydroxypropionic acid, itaconic acid, lactic acid, malic acid, malonic acid, oxalic acid, propionic acid, succinic acid, or xylonic acid. See, e.g., Chen and Lee, 1997, Appl. Biochem. Biotechnol. 63-65:435-448.
[0267] In another embodiment, the fermentation product is a polyketide.
[0268] collect The fermentation product, e.g., ethanol, can optionally be recovered from the fermentation medium using any method known in the art (e.g., but not limited to, chromatography, electrophoretic procedures, differential solubility, distillation, or extraction). For example, the alcohol can be separated from the fermented cellulosic material and purified by conventional distillation methods. Ethanol with a purity of up to about 96 vol% can be obtained and can be used, for example, as fuel ethanol, potable ethanol (i.e., potable neutral distilled spirits), or industrial ethanol.
[0269] In some embodiments of the methods, the fermentation product after recovery is substantially pure. With respect to the methods herein, "substantially pure" refers to a recovered preparation containing 15% or less impurities, where impurities refer to compounds other than the fermentation product (e.g., ethanol). In one variation, substantially pure preparations are provided that contain 25% or less impurities, or 20% or less impurities, or 10% or less impurities, or 5% or less impurities, or 3% or less impurities, or 1% or less impurities, or 0.5% or less impurities.
[0270] Suitable assays for testing ethanol and contaminant production and sugar consumption can be performed using methods known in the art. For example, ethanol production and other organic compounds can be analyzed by methods such as HPLC (high-performance liquid chromatography), GC-MS (gas chromatography-mass spectrometry), and LC-MS (liquid chromatography-mass spectrometry), or other suitable analytical methods using routine procedures known in the art. Ethanol release in the fermentation broth can also be tested through the culture supernatant. By-products and residual sugars (e.g., glucose or xylose) in the fermentation medium can be quantified, for example, by HPLC using a refractive index detector for glucose and alcohols and a UV detector for organic acids (Lin et al., Biotechnol. Bioeng. 90:775-779 (2005)), or other suitable assays and detection methods known in the art.
[0271] Deposit of biological materials The following biological materials have been deposited under the terms of the Budapest Treaty with the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA, and have been assigned the following accession numbers: Deposit Accession number Date of deposit Budding yeast (Saccharomyces cerevisiae) strain MBG5225 NRRL Y-68199 September 7, 2022 Budding yeast (Saccharomyces cerevisiae) strain MBG5227 NRRL Y-68200 September 7, 2022 Budding yeast (Saccharomyces cerevisiae) strain MBG5307 NRRL Y-68201 September 7, 2022 Budding yeast (Saccharomyces cerevisiae) strain MBG5318 NRRL Y-68202 September 7, 2022
[0272] The following biological material has been deposited under the terms of the Budapest Treaty at the National Measurement Institute, Victoria, Australia and has been given the following accession numbers: Deposit Accession number Date of deposit Ethanol Red(registered trademark) V14 / 007039 March 19, 2014
[0273] The strain was deposited under conditions ensuring that access to the culture will be available to those determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 C.F.R. § 1.14 and 35 U.S.C. § 122 during the pendency of this patent application. The deposit represents a substantially pure culture of the deposited strain. The deposit will be available as required by foreign patent laws in countries in which the subject application or its successor patent may be filed. It should be understood, however, that the availability of a deposit does not constitute authority to practice the subject invention in derogation of patent rights granted by governmental action.
[0274] The present invention described and claimed herein should not be limited in scope by the specific aspects or embodiments disclosed herein, as these aspects / embodiments are intended as illustrations of some aspects of the invention. Any equivalent aspects are intended to be within the scope of the invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In case of conflict, the present disclosure, including definitions, will control. All references are specifically incorporated by reference as to what is set forth.
[0275] The following examples are provided to illustrate certain aspects / embodiments of the present invention, but are not intended to limit the scope of the invention as claimed in any way. [Example]
[0276] Example 1: Generation of Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5318, and MBG5307 Strains MBG5225, MBG5227, MBG5307, and MBG5318 were obtained from a breeding and evolution program (e.g., following the breeding procedures described in U.S. Patent No. 8,257,959) that targeted improved fermentation performance for traits important for industrial corn ethanol production. The resulting strains were screened for improved ethanol titer, increased temperature tolerance, increased sugar consumption, high ethanol-to-glycerol ratio, and reduced by-products to maximize ethanol yield from corn mash fermentation.
[0277] Example 2: Fermentation of Saccharomyces cerevisiae strain MBG5225 under non-stress conditions Saccharomyces cerevisiae strain MBG5225 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids: 32.7% pH: 5.0 Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32℃ Scale: 80g Erlenmeyer flask
[0278] As shown in Figures 1 and 2, Saccharomyces cerevisiae strain MBG5225 showed improved ethanol yields and reduced glycerol levels when compared to Ethanol Red®.
[0279] Example 3: Fermentation of Saccharomyces cerevisiae strain MBG5227 under non-stress conditions Saccharomyces cerevisiae strain MBG5227 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids: 32.7% pH: 5.0 Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32℃ Scale: 80g Erlenmeyer flask
[0280] As shown in Figures 3 and 4, Saccharomyces cerevisiae strain MBG5227 showed improved ethanol yields and reduced glycerol levels when compared to Ethanol Red®.
[0281] Example 4: Fermentation of Saccharomyces cerevisiae strain MBG5318 under non-stress conditions Saccharomyces cerevisiae strain MBG5318 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids: 32.7% pH: 5.0 Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32℃ Scale: 80g Erlenmeyer flask
[0282] As shown in Figures 5 and 6, Saccharomyces cerevisiae strain MBG5318 showed improved ethanol yields and reduced glycerol levels when compared to Ethanol Red®.
[0283] Example 5: Fermentation of Saccharomyces cerevisiae strain MBG5307 under non-stress conditions Saccharomyces cerevisiae strain MBG5307 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids: 32.7% pH: 5.0 Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32℃ Scale: 80g Erlenmeyer flask
[0284] As shown in Figures 7 and 8, Saccharomyces cerevisiae strain MBG5307 showed improved ethanol yields and reduced glycerol levels when compared to Ethanol Red®.
[0285] Example 6: Fermentation of Saccharomyces cerevisiae strain MBG5225 under stress conditions Saccharomyces cerevisiae strain MBG5225 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids content: 31.9% Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32°C (7 hours) → 35°C (16 hours) → 32°C (31 hours) Scale: 80g Erlenmeyer flask
[0286] As shown in FIG. 9, Saccharomyces cerevisiae strain MBG5225 showed improved ethanol yields in the presence of organic acids (lactic acid plus acetic acid and higher temperatures) when compared to Ethanol Red®.
[0287] Example 7: Fermentation of Saccharomyces cerevisiae strain MBG5227 under stress conditions Saccharomyces cerevisiae strain MBG5227 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids content: 31.9% Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32°C (7 hours) → 35°C (16 hours) → 32°C (31 hours) Scale: 80g Erlenmeyer flask
[0288] As shown in FIG. 10, Saccharomyces cerevisiae strain MBG5227 showed improved ethanol yields in the presence of organic acids (lactic acid plus acetic acid and higher temperatures) when compared to Ethanol Red®.
[0289] Example 8: Fermentation of Saccharomyces cerevisiae strain MBG5318 under stress conditions Saccharomyces cerevisiae strain MBG5318 and Ethanol Red® were fermented under the following conditions: Mash: Liquozyme SC 4X Solids content: 31.9% Glucoamylose: Spirizyme Aceive T (Novozymes A / S) Glucoamylose dosage: 0.6 AGU / g (DS) Fermentation time: 54 hours Temperature: 32°C (7 hours) → 35°C (16 hours) → 32°C (31 hours) Scale: 80g Erlenmeyer flask
[0290] As shown in FIG. 11, Saccharomyces cerevisiae strain MBG5318 showed improved ethanol yield in the presence of organic acids (lactic acid plus acetic acid and higher temperatures) when compared to Ethanol Red®.
[0291] The invention may be further described in the following numbered paragraphs.
[0292] Paragraph [1]. A method for producing a fermentation product from a cellulose-containing and / or starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) with a fermentation organism under conditions suitable to produce a fermentation product, wherein the fermentation organism is a strain of Saccharomyces cerevisiae having deposit accession number NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermentation organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5225; A method comprising:
[0293] Paragraph [2]. A method for producing a fermentation product from a cellulose-containing and / or starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) with a fermentation organism under conditions suitable to produce a fermentation product, wherein the fermentation organism is a strain of Saccharomyces cerevisiae having deposit accession number NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermentation organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5227; A method comprising:
[0294] Paragraph [3]. A method for producing a fermentation product from a cellulose-containing and / or starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) with a fermentation organism under conditions suitable to produce a fermentation product, wherein the fermentation organism is a strain of Saccharomyces cerevisiae having deposit accession number NRRL Y-67971 (Saccharomyces cerevisiae strain MBG5307) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermentation organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5307; A method comprising:
[0295] Paragraph [4]. A method for producing a fermentation product from a cellulose-containing and / or starch-containing material, comprising: (a) saccharifying a cellulose-containing or starch-containing material; (b) fermenting the saccharified material of step (a) with a fermentation organism under conditions suitable to produce a fermentation product, wherein the fermentation organism is a strain of Saccharomyces cerevisiae having deposit accession number NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and / or an alpha-amylase), or a fermentation organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5318; A method comprising:
[0296] Paragraph [5]. The method of paragraphs [1] to [4], including a step of recovering a fermentation product from the fermentation.
[0297] Paragraph [6]. The method of Paragraph [5], wherein the step of recovering the fermentation product from the fermentation comprises distillation.
[0298] Paragraph [7]. The method of any one of paragraphs [1] to [6], wherein fermentation and saccharification are carried out simultaneously by simultaneous saccharification and fermentation (SSF).
[0299] Paragraph [8]. The method of any one of paragraphs [1] to [6], wherein fermentation and saccharification are carried out sequentially (SHF).
[0300] Paragraph [9]. The method of any one of paragraphs [1] to [8], wherein the fermentation product is ethanol.
[0301] Paragraph
[10] . The method of any one of Paragraphs [1] to [9], wherein step (a) comprises contacting the starch-containing material and / or the cellulose-containing material with an enzyme composition.
[0302] Paragraph
[11] . The method of any one of paragraphs [1] to
[10] , wherein step (a) comprises saccharifying the starch-containing material.
[0303] Paragraph
[12] . The method of Paragraph
[11] , wherein step (a) comprises: i) liquefying the starch-containing material at a temperature above the initial gelatinization temperature using an alpha-amylase; and ii) saccharifying the starch-containing material using a glucoamylase.
[0304] Paragraph
[13] . The process of any of paragraphs [1] to
[12] , wherein a protease is added during saccharification or fermentation or SSF.
[0305] Paragraph
[14] . Before the liquefaction step i): x) reducing the particle size of the starch-containing material, preferably by dry milling; y) forming a slurry comprising a starch-containing material and water; The process of any of paragraphs [1] to
[13] , further comprising:
[0306] Paragraph
[15] . The process of any of paragraphs [1]-
[14] , wherein at least 50%, e.g., at least 70%, at least 80%, or at least 90% of the starch-containing material barely passes through a sieve having a #6 screen.
[0307] Paragraph
[16] . The process of any of paragraphs [1] to
[15] , wherein the pH during liquefaction is between 4 and 7, such as between pH 4.5 and 6.5, for example between pH 5.0 and 6.5, for example between pH 5.0 and 6.0, for example between pH 5.2 and 6.2, such as about 5.2, for example about 5.4, for example about 5.6, for example about 5.8.
[0308] Paragraph
[17] . The process of any of Paragraphs [1] to
[16] , wherein the temperature during liquefaction is in the range of 70 to 100°C, e.g., 75 to 95°C, 75 to 90°C, 80 to 90°C, or 82 to 88°C, e.g., about 85°C.
[0309] Paragraph
[18] . The process of any of paragraphs [1] to
[17] , wherein a jet cooking step is carried out before liquefaction.
[0310] Paragraph
[19] . The process of paragraph
[18] , wherein the jet cooking is carried out at a temperature of 110 to 145°C, such as 120 to 140°C, for example 125 to 135°C, or about 130°C, for about 1 to 15 minutes, for example, about 3 to 10 minutes or about 5 minutes.
[0311] Paragraph
[20] . The process of any of Paragraphs [1] to
[19] , wherein saccharification is carried out at a temperature of 20 to 75°C, such as 40 to 70°C, for example about 60°C, and at a pH of 4 to 5.
[0312] Paragraph
[21] . The process of any of Paragraphs [1] to
[20] , wherein the fermentation or simultaneous saccharification and fermentation (SSF) is carried out at a temperature of 25° C. to 40° C., for example, 28° C. to 35° C., for example, 30° C. to 34° C., or about 32° C. In one embodiment, the fermentation proceeds for 6 to 120 hours, particularly 24 to 96 hours.
[0313] Paragraph
[22] . The process of any of paragraphs [1] to
[21] , wherein the starch-containing starting material is whole grain.
[0314] Paragraph
[23] . The process of any of paragraphs [1] to
[23] , wherein the starch-containing material is derived from corn, wheat, barley, rye, milo, sago, cassava, manioc, tapioca, sorghum, oats, rice, pea, or sweet potato.
[0315] Paragraph
[24] . The method of any one of paragraphs [1] to
[10] , wherein step (a) comprises saccharifying the cellulose-containing material.
[0316] Paragraph
[25] . The method of paragraph
[24] , wherein the cellulose-containing material is pretreated.
[0317] Paragraph
[26] . The method of either paragraph
[24] or
[25] , wherein the cellulose-containing material comprises bagasse.
[0318] Paragraph
[27] . The method of any of Paragraphs
[24] to
[26] , wherein step (a) comprises contacting the cellulose-containing material with an enzyme composition, the enzyme composition comprising one or more enzymes selected from cellulases, AA9 polypeptides, hemicellulases, CIPs, esterases, expansins, ligninolytic enzymes, oxidoreductases, pectinases, proteases, and swollenins.
[0319] Paragraph
[28] . The method of Paragraph
[27] , wherein the cellulase is one or more enzymes selected from endoglucanases, cellobiohydrolases, and beta-glucosidases.
[0320] Paragraph
[29] . The method of paragraphs
[27] or
[28] , wherein the hemicellulase is one or more enzymes selected from xylanase, acetyl xylan esterase, feruloyl esterase, arabinofuranosidase, xylosidase, and glucuronidase.
[0321] Paragraph
[30] . The method of any one of paragraphs [1] to
[29] , resulting in a fermentation product yield of at least 0.25% (e.g., 0.5%, 0.75%, 1.0%, 1.25%, 1.5%, 1.75%, 2%, 3%, or 5%).
[0322] Paragraph
[31] . The method of any one of paragraphs [1] to
[30] , wherein the fermentation is carried out under low-oxygen (e.g., anaerobic) conditions.
[0323] Paragraph
[32] . The method of any of paragraphs [1] to
[31] , wherein the fermenting organism has one or more of the following characteristics: Increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced maltose (DP2) production compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; and / or Reduction of glycerol production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions.
[0324] Paragraph
[33] . The process of any of paragraphs [1] to
[32] , wherein the fermenting organism achieves an ethanol yield boost of more than 0.5%, e.g., more than 1.0%, more than 2.0%, more than 2.5%, e.g., more than about 2.9%, e.g., 0.5 to 5%, e.g., 1 to 3%, relative to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, e.g., conditions described herein.
[0325] Paragraph
[34] . The process of any of paragraphs [1] to
[33] , wherein the fermenting organism reduces acetaldehyde production by more than 10%, such as more than 20%, more than 30%, more than 40%, more than 45%, such as 5 to 60%, such as 30 to 50%, compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, such as the process conditions described herein.
[0326] Paragraph
[35] . The process of any of paragraphs [1] to
[34] , wherein the fermenting organism has increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, e.g., the process conditions described herein.
[0327] Paragraph
[36] . The process of any of paragraphs [1] to
[35] , wherein the fermenting organism reduces maltose (DP2) production by more than 3%, for example, more than 4%, more than 5%, more than 6%, more than 7%, for example, 2 to 15%, for example, 5 to 10%, compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, for example, the conditions described herein.
[0328] Paragraph
[37] . The process of any of paragraphs [1] to
[36] , wherein the fermenting organism reduces glycerol production by more than 3%, such as more than 4%, more than 5%, more than 6%, more than 7%, such as 2 to 15%, for example 5 to 10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions, such as those described herein.
[0329] Paragraph
[38] . A Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) or a derivative thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5225.
[0330] Paragraph
[39] . A Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) or a derivative thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5227.
[0331] Paragraph
[40] . A Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) or a derivative thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5307.
[0332] Paragraph
[41] . A Saccharomyces cerevisiae strain having deposit accession number NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) or a derivative thereof (e.g., expressing a heterologous polypeptide such as glucoamylase and / or alpha-amylase) deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Treaty, or a fermenting organism having substantially the same characteristics as Saccharomyces cerevisiae MBG5318.
[0333] Paragraph
[42] . A Saccharomyces cerevisiae strain according to any one of paragraphs
[38] to
[41] , having one or more of the following characteristics: Increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; increased temperature tolerance compared to the Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced maltose (DP2) production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduction of glycerol production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited at the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions.
[0334] Paragraph
[43] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68199), comprising: a. culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5225, or a derivative thereof, under conditions that allow for combination of DNA between the first and second yeast strains; b. isolating the hybrid strain; c. optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as the first yeast strain and / or the second yeast strain; A method comprising:
[0335] Paragraph
[44] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68200), comprising: a. culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5227, or a derivative thereof, under conditions that allow for combination of DNA between the first and second yeast strains; b. isolating the hybrid strain; c. optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as the first yeast strain and / or the second yeast strain; A method comprising:
[0336] Paragraph
[45] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68201), comprising: a. culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5307, or a derivative thereof, under conditions that allow for combination of DNA between the first and second yeast strains; b. isolating the hybrid strain; c. optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as the first yeast strain and / or the second yeast strain; A method comprising:
[0337] Paragraph
[46] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68202), comprising: a. culturing a first yeast strain with a second yeast strain, the second yeast strain being Saccharomyces cerevisiae strain MBG5318, or a derivative thereof, under conditions that allow for combination of DNA between the first and second yeast strains; b. isolating the hybrid strain; c. optionally repeating steps (a) and (b) using the hybrid strain isolated in step (b) as the first yeast strain and / or the second yeast strain; A method comprising:
[0338] Paragraph
[47] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68199) that exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5225: (a) (i) a first yeast strain; (ii) a second yeast strain which is Saccharomyces cerevisiae strain MBG5225 or a derivative thereof; and preparing the (b) culturing the first yeast strain and the second yeast strain under conditions that allow for combination of DNA between the first yeast strain and the second yeast strain; (c) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5225; A method comprising:
[0339] Paragraph
[48] . The method of paragraph
[47] , wherein step (c) comprises screening or selecting hybrid strains that exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225.
[0340] Paragraph
[49] . (d) the method of paragraph
[47] , comprising the further step of repeating steps (a) and (b) with the screened or selected strain from step (c) as the first strain and / or the second strain until a derivative exhibiting the defining characteristics of Saccharomyces cerevisiae strain MBG5225 is obtained.
[0341] Paragraph
[50] . The culturing step (b) comprises: (i) sporulating a first yeast strain and a second yeast strain; (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain; The method of paragraph
[47] , including:
[0342] Paragraph
[51] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68200) that exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5227: (d) (j) a first yeast strain; (iii) a second yeast strain, which is Saccharomyces cerevisiae strain MBG5227 or a derivative thereof; and preparing the (e) culturing the first yeast strain and the second yeast strain under conditions that allow for combination of DNA between the first yeast strain and the second yeast strain; (f) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5227; A method comprising:
[0343] Paragraph
[52] . The method of Paragraph
[51] , wherein step (c) comprises screening or selecting hybrid strains that exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227.
[0344] Paragraph
[53] . (d) the method of paragraph
[51] , comprising the further step of repeating steps (a) and (b) with the screened or selected strain from step (c) as the first strain and / or the second strain until a derivative exhibiting the defining characteristics of Saccharomyces cerevisiae strain MBG5227 is obtained.
[0345] Paragraph
[54] . The culturing step (b) comprises: (i) sporulating a first yeast strain and a second yeast strain; (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain; The method of paragraph
[51] , including:
[0346] Paragraph
[55] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68201) that exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5307: (g) (k) a first yeast strain; (iv) a second yeast strain which is Saccharomyces cerevisiae strain MBG5307 or a derivative thereof; and preparing the (h) culturing the first yeast strain and the second yeast strain under conditions that allow for combination of DNA between the first yeast strain and the second yeast strain; (i) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5307; A method comprising:
[0347] Paragraph
[56] . The method of Paragraph
[55] , wherein step (c) comprises screening or selecting hybrid strains that exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307.
[0348] Paragraph
[57] . (d) the method of paragraph
[55] , comprising the further step of repeating steps (a) and (b) with the screened or selected strain from step (c) as the first strain and / or the second strain until a derivative exhibiting the defining characteristics of Saccharomyces cerevisiae strain MBG5307 is obtained.
[0349] Paragraph
[58] . The culturing step (b) comprises: (i) sporulating a first yeast strain and a second yeast strain; (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain; The method of paragraph
[55] , including:
[0350] Paragraph
[59] . A method for producing a derivative of Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68202) that exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5318: (j) (l) a first yeast strain; (v) a second yeast strain which is Saccharomyces cerevisiae strain MBG5318 or a derivative thereof; and preparing the (h) culturing the first yeast strain and the second yeast strain under conditions that allow for combination of DNA between the first yeast strain and the second yeast strain; (i) screening or selecting derivatives of Saccharomyces cerevisiae strain MBG5318; A method comprising:
[0351] Paragraph
[60] . The method of Paragraph
[59] , wherein step (c) comprises screening or selecting hybrid strains that exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318.
[0352] Paragraph
[61] . (d) the method of paragraph
[59] , comprising the further step of repeating steps (a) and (b) with the screened or selected strain from step (c) as the first strain and / or the second strain until a derivative exhibiting the defining characteristics of Saccharomyces cerevisiae strain MBG5318 is obtained.
[0353] Paragraph
[62] . The culturing step (b) comprises: (i) sporulating a first yeast strain and a second yeast strain; (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain; The method of paragraph
[59] , including:
[0354] Paragraph
[63] . A method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68199), comprising: (a) transforming Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225) with one or more expression vectors (e.g., one or more expression vectors encoding glucoamylase and / or alpha-amylase); (b) isolating the transformed strain; A method comprising:
[0355] Paragraph
[64] . A method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68200), comprising: (a) transforming Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) with one or more expression vectors (e.g., one or more expression vectors encoding glucoamylase and / or alpha-amylase); (b) isolating the transformed strain; A method comprising:
[0356] Paragraph
[65] . A method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68201), comprising: (a) transforming Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307) with one or more expression vectors (e.g., one or more expression vectors encoding glucoamylase and / or alpha-amylase); (b) isolating the transformed strain; A method comprising:
[0357] Paragraph
[66] . A method for producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5318 (deposited in the Agricultural Research Service Patent Culture Collection (NRRL) under accession number NRRL Y-68202), comprising: (a) transforming Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318) with one or more expression vectors (e.g., one or more expression vectors encoding glucoamylase and / or alpha-amylase); (b) isolating the transformed strain; A method comprising:
[0358] Paragraph
[67] . A Saccharomyces cerevisiae strain produced by any one of the methods set forth in paragraphs
[43] to
[66] .
[0359] Paragraph
[68] . A method for producing ethanol, comprising the step of incubating a Saccharomyces cerevisiae strain according to any of paragraphs
[38] to
[42] and
[67] with a substrate comprising fermentable sugars under conditions that allow fermentation of the fermentable sugars to produce ethanol.
[0360] Paragraph
[69] . Use of the Saccharomyces cerevisiae strain according to any one of paragraphs
[38] to
[42] and
[67] in the production of ethanol.
[0361] Paragraph
[70] . Use of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68199) in the production of a Saccharomyces strain having substantially the same properties as Saccharomyces cerevisiae strain MBG5225 or exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225.
[0362] Paragraph
[71] . Use of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68200) in producing a Saccharomyces strain having substantially the same properties as Saccharomyces cerevisiae strain MBG5227 or exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227.
[0363] Paragraph
[72] . Use of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68201) in the production of a Saccharomyces strain having substantially the same properties as Saccharomyces cerevisiae strain MBG5307 or exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307.
[0364] Paragraph
[73] . Use of Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68202) in producing a Saccharomyces strain having substantially the same properties as Saccharomyces cerevisiae strain MBG5318 or exhibiting one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318.
[0365] Paragraph
[74] . Use of Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68199), or a strain having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5225, or a derivative thereof, in a method according to any of paragraphs [1] and [5] to
[37] .
[0366] Paragraph
[75] . Use of Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68200), or a strain having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5227, or a derivative thereof, in a method according to any of paragraphs [2] and [5] to
[37] .
[0367] Paragraph
[76] . Use of Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68201), or a strain having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5307, or a derivative thereof, in a method according to any of paragraphs [3] and [5] to
[37] .
[0368] Paragraph
[77] . Use of Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68202), or a strain having substantially the same characteristics as Saccharomyces cerevisiae strain MBG5318, or a derivative thereof, in a method according to any of paragraphs [4] and [5] to
[37] .
[0369] Paragraph
[77] . A composition comprising the Saccharomyces cerevisiae strain of any of paragraphs
[38] to
[42] and
[67] and one or more naturally occurring and / or non-naturally occurring components.
[0370] Paragraph
[78] . The composition of Paragraph
[77] , wherein the component is selected from the group consisting of surfactants, emulsifiers, gums, swelling agents, and antioxidants.
[0371] Paragraph
[79] . The composition of Paragraph
[77] or
[78] , wherein the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5225 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68199).
[0372] Paragraph
[80] . The composition of Paragraph
[77] or
[78] , wherein the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5227 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68200).
[0373] Paragraph
[81] . The composition of Paragraph
[77] or
[78] , wherein the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5307 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y Y-68201).
[0374] Paragraph
[82] . The composition of Paragraph
[77] or
[78] , wherein the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5318 (deposited at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA under accession number NRRL Y-68202).
[0375] Paragraph
[83] . The composition of any of Paragraphs
[77] to
[82] , wherein the Saccharomyces cerevisiae strain is in a workable form, in particular in a dry form, a cream form, or a compressed form.
Claims
1. A process for producing ethanol from starch-containing materials: i) A step of liquefying the starch-containing material at a temperature exceeding the initial gelatinization temperature using alpha-amylase; ii) A process of saccharification using glucoamylase; iii) The process of fermentation using fermenting organisms and Including; The aforementioned fermenting organism is: (1) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having depositation number NRRL Y-68199 (budding yeast (Saccharomyces cerevisiae) strain MBG5225), deposited with the Aggregative Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5225; (2) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68200 (budding yeast (Saccharomyces cerevisiae) strain MBG5227), deposited with the Aggregative Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5227; (3) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68201 (budding yeast (Saccharomyces cerevisiae) strain MBG5307), deposited with the Aggregative Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5318; or (4) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68202 (budding yeast (Saccharomyces cerevisiae) strain MBG5318), deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermentation organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5318. That is the process.
2. (1) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having depositation number NRRL Y-68199 (budding yeast (Saccharomyces cerevisiae) strain MBG5225), deposited with the Aggregative Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5225; (2) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68200 (budding yeast (Saccharomyces cerevisiae) strain MBG5227), deposited with the Aggregative Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5227; (3) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68201 (budding yeast (Saccharomyces cerevisiae) strain MBG5307), deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermenting organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5318; and (4) A budding yeast (Saccharomyces cerevisiae) strain or derivative thereof (for example, expressing heterologous polypeptides such as glucoamylase and / or alpha-amylase), having deposit receipt number NRRL Y-68202 (budding yeast (Saccharomyces cerevisiae) strain MBG5318), deposited with the Agricultural Research Service Patent Culture Collection (NRRL) under the Budapest Convention, or a fermentation organism having substantially the same characteristics as budding yeast (Saccharomyces cerevisiae) MBG5318. A yeast strain of the genus Saccharomyces selected from the following.
3. The aforementioned stocks are: Increased ethanol yield compared to the budding yeast strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced acetaldehyde production compared to the budding yeast strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Increased temperature tolerance compared to the budding yeast strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; Reduced maltose (DP2) production compared to the budding yeast strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions; and Reduced glycerol production compared to the budding yeast strain Ethanol Red® (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039) under the same process conditions. A Saccharomyces yeast strain according to claim 1 or 2, comprising one or more characteristics and defining features selected from the above.
4. The aforementioned strain is a Saccharomyces yeast strain according to claim 1 or 2, which can achieve an ethanol yield boost of more than 1.0% compared to the budding yeast (Saccharomyces cerevisiae) strain Ethanol Red® (registered trademark) (deposited with the National Measurement Institute, Victoria, Australia under accession number V14 / 007039).
5. A method for producing derivatives of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318): (a) A step of culturing a first yeast strain together with a second yeast strain which is NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), or a derivative thereof, under conditions that enable DNA combination between the first yeast strain and the second yeast strain; (b) Steps to isolate the hybrid strain A method that includes this.
6. NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) showing the definitive characteristics of budding yeast (Saccharomyces cerevisiae) strain MBG5225, NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) showing the definitive characteristics of budding yeast (Saccharomyces cerevisiae) strain MBG5307, NRRL Y-68201 (Saccharomyces A method for producing a derivative of NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) exhibiting the defining characteristics of Saccharomyces cerevisiae strain MBG5307, or Saccharomyces cerevisiae strain MBG5318: (a) (i) a step of preparing a first yeast strain and (ii) a second yeast strain which is NRRL Y-68199 (budding yeast (Saccharomyces cerevisiae) strain MBG5225), NRRL Y-68200 (budding yeast (Saccharomyces cerevisiae) strain MBG5227), NRRL Y-68201 (budding yeast (Saccharomyces cerevisiae) strain MBG5307), or NRRL Y-68202 (budding yeast (Saccharomyces cerevisiae) strain MBG5318), or a derivative thereof; (b) A step of culturing the first yeast strain and the second yeast strain under conditions that enable the combination of DNA between the first yeast strain and the second yeast strain; (c) A step of screening or selecting derivatives of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) A method that includes this.
7. The method according to claim 6, further comprising step (c) screening or selecting a hybrid strain exhibiting one or more defining characteristics of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318).
8. The method of claim 6, further comprising (d) repeating steps (b) and (c) with the first strain and / or second strain, a screening strain or selected strain derived from step (c), until a derivative exhibiting the defining characteristics of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318).
9. The culture step (b) is: (i) a step of causing the first yeast strain and the second yeast strain to form spores; (ii) A step of hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain. The method according to claim 6, including the method described in claim 6.
10. A strain of the genus Saccharomyces produced by the method of claim 6.
11. A method for producing ethanol, comprising the step of incubating the strain described in claim 2 with a substrate containing a fermentable sugar and under conditions that enable the fermentation of the fermentable sugar to produce ethanol.
12. A method for producing distilled grains, which is: (a) A step of incubating a Saccharomyces strain according to claim 2 with a substrate containing a fermentable sugar and under conditions that enable the fermentation of the fermentable sugar to produce ethanol and distilled grain; (b) A step of isolating the distilled grains A method that includes this.
13. Distilled grain produced by the method of claim 12.
14. A composition comprising a Saccharomyces yeast strain as described in claim 2, and one or more naturally occurring and / or non-naturally occurring components selected from surfactants, emulsifiers, gums, swelling agents, and antioxidants.
15. A method for producing a recombinant derivative of Saccharomyces yeast according to claim 2, comprising introducing nucleic acids into Saccharomyces yeast according to claim 2 using recombinant DNA technology.
16. The method according to claim 15, wherein the introduced nucleic acid expresses glucoamylase and / or alpha-amylase.
17. A recombinant derivative of the genus Saccharomyces yeast produced by the method of claim 15.
18. The introduced nucleic acid is a Saccharomyces strain according to claim 17, expressing glucoamylase and / or alpha-amylase.
19. A composition comprising a recombinant derivative of a Saccharomyces yeast strain according to claim 17, and one or more components selected from surfactants, emulsifiers, gums, swelling agents, and antioxidants.
